medp-10q_20170630.htm

0001564590-17-014638.txt : 20170801 0001564590-17-014638.hdr.sgml : 20170801 20170801160325 ACCESSION NUMBER: 0001564590-17-014638 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20170630 FILED AS OF DATE: 20170801 DATE AS OF CHANGE: 20170801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medpace Holdings, Inc. CENTRAL INDEX KEY: 0001668397 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 320434904 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37856 FILM NUMBER: 17996734 BUSINESS ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 BUSINESS PHONE: (513) 579-9911 MAIL ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 10-Q 1 medp-10q_20170630.htm 10-Q medp-10q_20170630.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2017

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to .

Commission file number: 001-37856

Medpace Holdings, Inc.

(Exact name of registrant as specified in its charter)

Delaware

32-0434904

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

5375 Medpace Way, Cincinnati, OH 45227

(Address of principal executive offices) (Zip Code)

(513) 579-9911

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐		Accelerated filer	☐
Non-accelerated filer	☒	(Do not check if a smaller reporting company)	Smaller reporting company	☐
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock, as of the latest practicable date.

Class		Number of Shares Outstanding
Common Stock $0.01 par value		39,486,848 shares outstanding as of July 28, 2017

MEDPACE HOLDINGS, INC. AND SUBSIDIARIES

FORM 10-Q

FOR QUARTERLY PERIOD ENDED JUNE 30, 2017

TABLE OF CONTENTS

Item Number		Page
	PART I — FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited)
	Condensed Consolidated Balance Sheets as of June 30, 2017 and December 31, 2016	3
	Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2017 and 2016	4
	Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2017 and 2016	5
	Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2017 and 2016	6
	Notes to Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	26
Item 4.	Controls and Procedures	26

	PART II — OTHER INFORMATION	27
Item 1.	Legal Proceedings	27
Item 1A.	Risk Factors	27
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	28
Item 3.	Defaults Upon Senior Securities	29
Item 4.	Mine Safety Disclosures	29
Item 5.	Other Information	29
Item 6.	Exhibits	29
SIGNATURES		30
EXHIBIT INDEX		31

- 2 -

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

MEDPACE HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(Amounts in thousands, except share amounts)	As Of
	June 30,			December 31.
	2017			2016
ASSETS
Current assets:
Cash and cash equivalents	$	29,055		$	37,099
Restricted cash		275			308
Accounts receivable and unbilled, net (includes $1.2 million and $2.3 million with related parties at June 30, 2017 and December 31, 2016, respectively)		76,664			79,767
Prepaid expenses and other current assets		17,129			16,074
Total current assets		123,123			133,248
Property and equipment, net		45,244			43,805
Goodwill		660,981			660,981
Intangible assets, net		117,676			136,071
Deferred income taxes		11,536			97
Other assets		5,086			4,903
Total assets	$	963,646		$	979,105
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	7,195		$	10,911
Accrued expenses		16,392			24,417
Pre-funded study costs (includes $1.5 million and $3.9 million with related parties at June 30, 2017 and December 31, 2016, respectively)		48,530			51,948
Advanced billings (includes $4.2 million and $7.6 million with related parties at June 30, 2017 and December 31, 2016, respectively)		65,577			65,668
Current portion of long-term debt		14,438			12,375
Other current liabilities		3,130			3,284
Total current liabilities		155,262			168,603
Long-term debt, net, less current portion		143,191			151,267
Deemed landlord liability, less current portion		27,591			28,527
Deferred income tax liability		481			12,030
Deferred credit		21,420			-
Other long-term liabilities		8,343			7,968
Total liabilities		356,288			368,395
Commitments and contingencies (see Note 11)
Shareholders’ equity:
Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively		-			-
Common stock - $0.01 par-value; 250,000,000 shares authorized at June 30, 2017 and December 31, 2016, respectively; 39,692,999 and 40,662,856 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively		398			407
Additional paid-in capital		627,407			623,629
Accumulated deficit		(18,419	)		(9,584	)
Accumulated other comprehensive loss		(2,028	)		(3,742	)
Total shareholders’ equity		607,358			610,710
Total liabilities and shareholders’ equity	$	963,646		$	979,105

See notes to condensed consolidated financial statements.

- 3 -

MEDPACE HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(Amounts in thousands, except per share amounts)	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2017			2016			2017			2016
Revenue:
Service revenue, net (includes $2.9 million and $4.6 million with related parties for the three months ended June 30, 2017 and 2016, respectively, and $6.9 million and $12.4 million with related parties for the six months ended June 30, 2017 and 2016)	$	94,552		$	92,633		$	188,333		$	180,433
Reimbursed out-of-pocket revenue (includes $0.4 million and $1.7 million with related parties for the three months ended June 30, 2017 and 2016, respectively, and $1.1 million and $2.9 million with related parties for the six months ended June 30, 2017 and 2016)		11,664			13,321			24,494			25,107
Total revenue		106,216			105,954			212,827			205,540
Operating expenses:
Direct costs, excluding depreciation and amortization		51,955			49,234			103,060			96,215
Reimbursed out-of-pocket expenses (includes $0.4 million and $1.7 million with related parties for the three months ended June 30, 2017 and 2016, respectively, and $1.1 million and $2.9 million with related parties for the six months ended June 30, 2017 and 2016)		11,664			13,321			24,494			25,107
Selling, general and administrative		14,755			14,824			29,909			28,333
Depreciation		2,101			1,793			4,231			3,566
Amortization		9,462			12,668			18,910			25,336
Total operating expenses		89,937			91,840			180,604			178,557
Income from operations		16,279			14,114			32,223			26,983
Other expense, net:
Miscellaneous expense, net		(125	)		(6	)		(497	)		(941	)
Interest expense, net		(1,808	)		(5,921	)		(3,602	)		(11,894	)
Total other expense, net		(1,933	)		(5,927	)		(4,099	)		(12,835	)
Income before income taxes		14,346			8,187			28,124			14,148
Income tax provision		4,793			3,225			10,124			5,738
Net income	$	9,553		$	4,962		$	18,000		$	8,410
Net income per share attributable to common shareholders:
Basic	$	0.24		$	0.15		$	0.44		$	0.26
Diluted	$	0.23		$	0.15		$	0.44		$	0.26
Weighted average common shares outstanding:
Basic		40,183			32,636			40,425			32,631
Diluted		40,825			32,828			41,158			32,631

See notes to condensed consolidated financial statements.

- 4 -

MEDPACE HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

(Amounts in thousands)	Three Months Ended					Six Months Ended
	June 30,					June 30,
	2017		2016			2017		2016
Net income	$	9,553	$	4,962		$	18,000	$	8,410
Other comprehensive income (loss)
Foreign currency translation adjustments, net of taxes		1,118		(564	)		1,714		8
Comprehensive income	$	10,671	$	4,398		$	19,714	$	8,418

See notes to condensed consolidated financial statements.

- 5 -

MEDPACE HOLDINGS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(Amounts in thousands)	Six Months Ended
	June 30,
	2017			2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	18,000		$	8,410
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation		4,231			3,566
Amortization		18,910			25,336
Stock-based compensation expense		2,234			4,275
Amortization of debt issuance costs and discount		332			1,345
Deferred income tax benefit		(864	)		(483	)
Other		(744	)		(207	)
Changes in assets and liabilities:
Accounts receivable and unbilled, net		3,405			(24,825	)
Prepaid expenses and other current assets		(519	)		(8,551	)
Accounts payable		(2,855	)		(2,112	)
Accrued expenses		(8,398	)		(1,461	)
Pre-funded study costs		(3,510	)		2,372
Advanced billings		(294	)		15,017
Other assets and liabilities, net		(195	)		(2,191	)
Net cash provided by operating activities		29,733			20,491
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment expenditures		(6,019	)		(5,693	)
Acquisition of intangibles		(515	)		-
Other		29			40
Net cash used in investing activities		(6,505	)		(5,653	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from stock option exercises		955			102
Repurchases of common stock		(26,405	)		-
Payment of debt		(6,187	)		(15,036	)
Payment of deemed landlord liability		(813	)		(744	)
Net cash used in financing activities		(32,450	)		(15,678	)
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH		1,145			143
DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH		(8,077	)		(697	)
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — Beginning of period		37,407			17,737
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — End of period	$	29,330		$	17,040

See notes to condensed consolidated financial statements.

- 6 -

MEDPACE HOLDINGS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

June 30, 2017

(1) Basis of Presentation

Description of Business

Medpace Holdings, Inc. together with its subsidiaries, (“Medpace” or the “Company”), a Delaware corporation, is a global provider of clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials.

The Company’s operations are principally based in North America, Europe, and Asia.

Unaudited Interim Financial Information

The interim condensed consolidated financial statements include the accounts of the Company, are prepared in conformity with U.S. generally accepted accounting principles (“GAAP”), and are unaudited. In the opinion of the Company’s management, all adjustments of a normal recurring nature necessary for a fair presentation have been reflected. Certain financial information that is normally included in annual financial statements prepared in accordance with GAAP, but that is not required for interim reporting purposes, has been omitted. The preparation of the interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the interim condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results and outcomes could differ from management’s estimates and assumptions. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the Company’s audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

Share Repurchases

In April 2017, the Board of Directors (the “Board”) of the Company authorized a share repurchase program with an authorized repurchase level of $50.0 million. The share repurchase program, according to its terms, will expire in April 2018. Repurchases under the repurchase program may take place in the open market or negotiated transactions, at the discretion of the Company’s management. During the three and six months ended June 30, 2017, the Company repurchased 1,042,455 shares of its outstanding common stock for $26.4 million.

Recently Adopted Accounting Standards

In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-01, Business Combinations. The standard changes the definition of a business to assist entities with evaluating when a set of transferred assets and activities is a business. Under the new guidance, an entity first determines whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the set is not a business. If it’s not met, the entity then evaluates whether the set meets the requirement that a business include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create outputs. ASU 2017-01 is effective for fiscal years beginning after December 15, 2017, and for interim periods within those fiscal years. The Company, as permitted, early adopted ASU 2017-01 using the prospective method in the second quarter of 2017. ASU 2017-01 was considered in the asset acquisition described in Note 2.

In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The new guidance is intended to reduce diversity in practice by requiring the statement of cash flows to explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017, and for interim periods within those fiscal years. The Company, as permitted, early adopted ASU 2016-18 in the fourth quarter of 2016. As a result of this adoption, cash flows resulting from changes in restricted cash balances, are no longer presented as a component of net cash provided by operating activities in the Company’s condensed consolidated statements of cash flows, but have been reclassified and combined within Increases/(Decreases) in Cash and Cash Equivalents and Restricted Cash. This reclassification was retrospectively applied to all periods presented within the condensed consolidated statements of cash flows.

- 7 -

In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting. The new guidance is intended to simplify certain aspects of accounting for share based payments to employees, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The Company elected to adopt this ASU in the first quarter of 2017 as required. The following summarizes the effects of the adoption on the Company's condensed consolidated financial statements:

•

Income taxes - Upon adoption of this standard, all excess tax benefits and tax deficiencies (including tax benefits of dividends, if distributed, on share-based payment awards) are recognized as income tax expense or benefit in the statement of operations. The tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. As a result, the Company recognized discrete adjustments to income tax expense for the six months ended June 30, 2017 of less than $0.1 million related to excess tax benefits. The Company also recognizes excess tax benefits regardless of whether the benefit reduces taxes payable in the current period. The Company applied the prospective adoption approach for any unrecognized excess tax benefits beginning in 2017, which did not result in any cumulative-effect adjustment upon adoption. Prior periods have not been adjusted.

•

Forfeitures - Prior to adoption, share-based compensation expense was recognized on a straight line basis, net of estimated forfeitures, such that expense was recognized only for share-based awards that were expected to vest. A forfeiture rate was estimated annually and revised, if necessary, in subsequent periods if actual forfeitures differed from initial estimates. Upon adoption, the Company no longer applies a forfeiture rate and instead accounts for forfeitures as they occur. The Company applied the modified retrospective adoption approach beginning in 2017 and booked an immaterial cumulative-effect adjustment to additional paid-in-capital and retained earnings within Shareholders’ Equity. Prior periods have not been adjusted.

•

Statements of Cash Flows - The Company historically accounted for excess tax benefits on the Statement of Cash Flows as a financing activity. Upon adoption of this standard, excess tax benefits are classified along with other income tax cash flows as an operating activity. The Company elected to adopt this portion of the standard on a prospective basis beginning in 2017. Prior periods have not been adjusted.

•

Earnings Per Share - The Company uses the treasury stock method to compute diluted earnings per share, unless the effect would be anti-dilutive. Under this method, the Company is no longer required to estimate the tax rate and apply it to the dilutive share calculation for determining the dilutive earnings per share. The Company utilized the prospective adoption approach and applied this methodology beginning in 2017. Prior periods have not been adjusted.

Upon adoption, no other aspects of ASU 2016-09 had an effect on the Company's condensed consolidated financial statements or related footnote disclosures.

Recently Issued Accounting Standards

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The guidance in ASU 2016-02 supersedes the lease recognition requirements in ASC Topic 840, Leases (FAS 13). ASU 2016-02 requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases, along with additional qualitative and quantitative disclosures. ASU 2016-02 will be applied on a modified retrospective basis to each prior reporting period presented and is effective for fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is currently evaluating the effect this standard will have on its condensed consolidated financial statements.

In May 2014, the FASB issued ASU No. 2014-09 ‘‘Revenue from Contracts with Customers,’’ to clarify the principles of recognizing revenue and create common revenue recognition guidance between US GAAP and International Financial Reporting Standards. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net). In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. In May 2016, the FASB issued ASU 2016-12, Narrow-Scope Improvements and Practical Expedients. In December 2016, the FASB issued ASU 2016-20 Technical Corrections and Improvements to Topic 606, Revenue From Contracts with Customers. ASUs’ 2016-20, 2016-12, 2016-10 and 2016-08 all clarify the interpretation guidance in ASU No. 2014-09, “Revenue from Contracts with Customers” specifically related to narrowing specific aspects of Topic 606 and adding illustrative examples to assist in the application of the guidance. The effective date and transition requirements in ASUs’ 2016-20, 2016-12, 2016-10, and 2016-08 are the same as the effective date and transition requirements of ASU 2014-09. ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, deferred the original effective date of ASU 2014-09 by one year. The new standard allows for either a retrospective or modified retrospective approach to transition upon adoption. The new standard will be effective for annual reporting periods beginning after December 15, 2017. Early adoption is permitted for annual reporting periods beginning after December 15, 2016.

- 8 -

The Company continues to progress in its evaluation of potential impact of adopting this standard on its business policies, processes and systems, internal control over financial reporting environment, and financial reporting and disclosures. The Company expects that the majority of its contracts will have a single performance obligation and continues to assess the best measure of progress for recognition purposes. The Company will adopt ASU 2014-09 as well as the clarified guidance in ASUs’ 2016-20, 2016-12, 2016-10, 2016-08, utilizing the modified retrospective approach, during the first quarter of 2018.

(2) Acquisition

In May 2017, the Company acquired out of bankruptcy NephroGenex, Inc. (“Nephrogenex” or the “Debtor”), a publicly-held pharmaceutical company that had previously filed for relief under Chapter 11 of the United States Bankruptcy Code. The Company, which was the largest unsecured creditor of Nephrogenex, entered into an agreement through the bankruptcy process, to exchange its unsecured claim for 100% of the common stock in the post-bankruptcy, debt free Debtor. The assets of the acquired Debtor consist primarily of tax attributes as well as in-process research and development and other intangible assets. An analysis by the Company determined that substantially all the fair value of the assets on the date of acquisition is captured in the tax attributes, as the intangible assets account for a relatively immaterial portion of the fair market value of the total assets received. The acquisition of the Debtor was accounted for as an asset purchase.

The Company allocated its consideration paid of $1.2 million, consisting of accounts receivable and unbilled receivables and transaction related costs, on a pro rata basis to the assets acquired based on their respective fair values. Acquired assets include intangible assets of $0.5 million, deferred tax assets of $22.2 million, consisting of tax effected net operating losses in the amount of $21.1 (partially offset with a $7.6 million valuation allowance), tax effected capitalized research and development expenses of $8.5 million and tax effected federal tax credits of $1.4 million (partially offset with a $1.2 million valuation allowance) and deferred tax liabilities of $0.1 million. The excess amount of fair value received over consideration paid of $21.4 million was recorded as a Deferred credit in the condensed consolidated balance sheets and will be recognized within Income tax provision in proportion to the realization of the deferred tax assets and federal tax credits prospectively.

(3) Net Income Per Share

Basic and diluted earnings or loss per share (“EPS”) are computed using the two-class method, which is an earnings allocation that determines EPS for each class of common stock and participating securities according to dividends declared and participation rights in undistributed earnings. Restricted Stock Awards (“RSAs”) are considered participating securities because they are legally issued at the date of grant and holders are entitled to receive non-forfeitable dividends during the vesting term.

The computation of diluted EPS includes additional common shares, such as unvested stock options with exercise prices less than the average market price of the Company’s common stock during the period (“in-the-money options”), which would be considered outstanding under the treasury stock method. The treasury stock method assumes that additional shares would have to be issued in cases where the exercise price of stock options is less than the value of the common stock being acquired because the cash proceeds received from the stock option holder would not be sufficient to acquire that same number of shares. The Company does not compute diluted EPS in cases where the inclusion of such additional shares would be anti-dilutive in effect.

- 9 -

The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2017 and 2016, (in thousands, except for earnings per share):


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Weighted-average shares:
Common shares outstanding		40,183		32,636		40,425		32,631
RSAs		59		-		59		-
Total weighted-average shares		40,242		32,636		40,484		32,631
Earnings per common share—Basic
Net income	$	9,553	$	4,962	$	18,000	$	8,410
Less: Undistributed earnings allocated to RSAs		14		-		26		-
Net income available to common shareholders—Basic	$	9,539	$	4,962	$	17,974	$	8,410

Net income per common share—Basic	$	0.24	$	0.15	$	0.44	$	0.26

Basic weighted-average common shares outstanding		40,183		32,636		40,425		32,631
Effect of diluted shares		642		192		733		-
Diluted weighted-average shares outstanding		40,825		32,828		41,158		32,631

Net income per common share—Diluted	$	0.23	$	0.15	$	0.44	$	0.26

During the three months ended June 30, 2017, there were 15,030 shares excluded from the computation of EPS because they were anti-dilutive under the treasury method calculation of diluted weighted average shares outstanding. During the six months ended June 30, 2017 and 2016, respectively, there were 46,124 and 25,584 shares excluded from the computation of EPS because they were anti-dilutive under the treasury method calculation of diluted weighted average shares outstanding.

During the three months ended June 30, 2017, there were 697,850 stock options that were excluded from the computation of EPS due to the exercise price exceeding the average fair value of the Company’s common stock during the period. During the six months ended June 30, 2017 and 2016, respectively, there were 27,500 and 186,667 stock options that were excluded from the computation of EPS due to the exercise price exceeding the average fair value of the Company’s common stock during the period.

(4) Fair Value Measurements

The Company follows accounting guidance related to fair value measurements that defines fair value, establishes a framework for measuring fair value, and establishes a hierarchy for inputs used in measuring fair value. This hierarchy maximizes the use of “observable” inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy specifies three levels based on the inputs, as follows:

Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities.

Level 2: Valuations based on directly observable inputs or unobservable inputs corroborated by market data.

Level 3: Valuations based on unobservable inputs supported by little or no market activity representing management’s determination of assumptions of how market participants would price the assets or liabilities.

The fair value of financial instruments such as cash and cash equivalents, accounts receivable and unbilled, net, accounts payable, accrued expenses and advanced billings approximate their carrying amounts due to their short term maturities.

The Company does not have any recurring fair value measurements as of June 30, 2017. There were no transfers between Level 1, Level 2 or Level 3 during the three or six months ended June 30, 2017 and 2016.

- 10 -

(5) Accounts Receivable And Unbilled, Net

Accounts receivable and unbilled, net includes service revenue and reimbursed out-of-pocket revenue. Accounts receivable and unbilled, net consisted of the following (in thousands):

	As of
	June 30,		December 31,
	2017		2016
Accounts receivable	$	50,606	$	48,270
Unbilled	28,164			34,719
Less allowance for doubtful accounts	(2,106)		(3,222)
Total accounts receivable and unbilled, net	$	76,664	$	79,767

(6) Intangible Assets, Net

Intangible assets, net consisted of the following (in thousands):

	As of
	June 30,			December 31,
	2017			2016
Intangible assets:
Finite-lived intangible assets:
Carrying amount:
Backlog	$	72,630		$	72,630
Customer relationships		145,051			145,051
Developed technologies		54,475			54,475
Other		3,020			2,505
Total finite-lived intangible assets		275,176			274,661
Accumulated amortization:
Backlog		(72,630	)		(72,630	)
Customer relationships		(79,464	)		(66,267	)
Developed technologies		(35,409	)		(29,961	)
Other		(1,643	)		(1,378	)
Total accumulated amortization		(189,146	)		(170,236	)
Total finite-lived intangible assets, net		86,030			104,425
Trade name (indefinite-lived)		31,646			31,646
Total intangible assets, net	$	117,676		$	136,071

As of June 30, 2017, estimated amortization expense of the Company’s intangible assets for each of the next five years and thereafter is as follows (in thousands):

	Amortization
Remainder of 2017	$	18,981
2018		29,543
2019		14,810
2020		7,869
2021		5,114
Later years		9,713
	$	86,030

- 11 -

(7) Accrued Expenses

Accrued expenses consisted of the following (in thousands):

	As of
	June 30,		December 31,
	2017		2016
Employee compensation and benefits	$	13,191	$	21,453
Other		3,201		2,964
Total accrued expenses	$	16,392	$	24,417

(8) Debt

Debt consisted of the following (in thousands):

	As of
	June 30,			December 31,
	2017			2016

Term loan	$	158,813		$	165,000
Less unamortized discount		(466	)		(534	)
Less unamortized term loan debt issuance costs		(718	)		(824	)
Less current portion of long-term debt		(14,438	)		(12,375	)
Long-term debt, net, less current portion	$	143,191		$	151,267

Principal payments on debt are due as follows (in thousands):

2017 (remaining)	$	6,188
2018		16,500
2019		16,500
2020		20,625
2021		99,000
Total	$	158,813

The estimated fair value of the Company’s term loan based on Level 2 inputs using the market approach, which is primarily based on rates at which the debt is traded among financial institutions, approximates the carrying value as of June 30, 2017 and December 31, 2016.

(9) Shareholder’s Equity and Stock-Based Compensation

The Company granted 27,500 and 727,550 stock option awards, vesting after four years, to employees under the 2016 Incentive Award Plan, during the three and six months ended June 30, 2017. The Company granted an additional 41,346 stock option awards, vesting after one year, to non-employee directors under the 2016 Incentive Award Plan, during the three and six months ended June 30, 2017. The Company granted 34,812 stock options vesting equally over four years and 11,111 restricted awards, which immediately vested upon issuance, to employees under the 2014 Equity Incentive Plan during the six months ended June 30, 2016.

- 12 -

Award Activity

The following table sets forth the Company’s stock option activity:

	Six Months Ended June 30, 2017
				Weighted Average
	Stock Options			Exercise Price
Outstanding - beginning of period		2,350,166		$	17.57
Granted		768,896		$	28.35
Exercised		(72,579	)	$	15.24
Forfeited/Expired		(125,707	)	$	20.80
Outstanding - end of period		2,920,776		$	20.32

Exercisable - end of period		859,212		$	15.34

The following table sets forth the Company’s Restricted Share activity:

	Six Months Ended
	June 30, 2017
	Shares
Outstanding and unvested - beginning of period		59,258
Granted		-
Vested		-
Forfeited		-
Outstanding and unvested - end of period		59,258

Cumulative vested shares - end of period		1,854,658

Stock-based compensation expense recognized in the condensed consolidated statements of operations related to all outstanding stock based compensation awards is summarized below (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2017		2016		2017		2016
Direct costs, excluding depreciation and amortization	$	573	$	1,911	$	1,115	$	2,474
Selling, general and administrative		627		1,355		1,119		1,801
Total stock-based compensation expense	$	1,200	$	3,266	$	2,234	$	4,275

(10) Income Taxes

The Company’s effective income tax rate was 33.4% and 36.0% for the three and six months ended June 30, 2017, respectively. The Company’s effective income tax rate was 39.4% and 40.6% for the three and six months ended June 30, 2016, respectively. The Company’s effective income tax rate for the three and six months ended June 30, 2017 varied from the U.S. statutory rate of 35.0% primarily due to the impact of state taxes, domestic and foreign uncertain tax positions and the tax impact associated with acquired tax attributes.

The Company acquired deferred tax assets of $22.2 million, consisting of tax effected net operating losses in the amount of $21.1 (partially offset with a $7.6 million valuation allowance), tax effected capitalized research and development expenses of $8.5 million and tax effected federal tax credits of $1.4 million (partially offset with a $1.2 million valuation allowance) and deferred tax liabilities of $0.1 million. See Note 2 for further description of the asset acquisition that occurred in the second quarter of 2017.

(11) Commitments and Contingencies

Legal Proceedings

The Company is involved in legal proceedings from time to time in the ordinary course of its business, including employment claims and claims related to other business transactions. The Company cannot predict with certainty the outcome of such proceedings, but it believes that adequate reserves have been recorded and losses already recognized with respect to such actions were immaterial as of

- 13 -

June 30, 2017 and December 31, 2016. There is a reasonable possibility that a loss exceeding amounts already recognized may be incurred related to these actions; however, the Company believes that such potential losses were immaterial as of June 30, 2017.

(12) Related Party Transactions

Employee Loans

The Company periodically extends short term loans or advances to employees, typically upon commencement of employment. Total receivables as a result of these employee advances of $0.2 million existed at June 30, 2017 and December 31, 2016, respectively, and are included in the Prepaid expenses and other current assets and Other assets line items of the condensed consolidated balance sheets, respectively, depending on the contractual repayment date.

Management Fees

In conjunction with the IPO, the Advisory Services Agreement with Cinven Capital Management (V) General Partner Limited (“Cinven”) expired. Subsequent to the IPO, the Company pays fees for director services provided by Cinven employees that are members of the Company’s Board of Directors and any related committees. The director fees are paid directly to Cinven in accordance with the Company’s non-employee director compensation policy. During the three and six months ended June 30, 2016, the Company incurred management fees to Cinven of $0.1 million and $0.2 million, respectively, in the Company’s condensed consolidated statements of operations.

Service Agreements

Symplmed Pharmaceuticals, LLC (“Symplmed”)

Medpace Investors LLC, a noncontrolling shareholder of the Company that is owned by employees of the Company and managed by the Company’s chief executive officer, has a majority ownership interest in Symplmed, a private pharmaceutical development company. In addition, the chief executive officer and other executives of the Company are board members of Symplmed. The Company has operated under a Master Services Agreement (“MSA”) with Symplmed since 2013 (amended in 2014) to perform clinical trial related services. Certain task orders governed by this arrangement were amended in the third quarter of 2016, changing the fee structure from unitized in nature to time and materials and revised pricing to more appropriately reflect market pricing based on the Company’s leveraging of this work to develop and enhance certain new service capabilities. The Company has evaluated its relationship with Symplmed and concluded that Symplmed is not a variable interest entity because the Company has no direct ownership interest or relationship other than the MSA. During the three months ended June 30, 2017 and 2016, the Company recognized service revenue from Symplmed of less than $0.1 million and $0.1 million, respectively, and during the six months ended June 30, 2017 and 2016, the Company recognized service revenue from Symplmed of less than $0.1 million and $0.4 million, respectively, in the Company’s condensed consolidated statements of operations.

Coherus BioSciences, Inc. (“Coherus”)

The chief executive officer of the Company is a member of Coherus’s board of directors. During the three months ended June 30, 2017 and 2016, the Company recognized service revenue from Coherus of $1.8 million and $4.3 million, respectively, and during the six months ended June 30, 2017 and 2016, the Company recognized service revenue from Coherus of $5.1 million and $11.4 million, respectively, in the Company’s condensed consolidated statements of operations. In addition, the company recognized Reimbursed out-of-pocket revenue and Reimbursed out-of-pocket expenses with Coherus in the condensed consolidated statements of operations of $0.4 million and $1.6 million during the three months ended June 30, 2017 and 2016, respectively, and $1.0 million and $2.9 million during the six months ended June 30, 2017 and 2016. As of June 30, 2017 and December 31, 2016, respectively, the Company had Accounts receivable and unbilled, net from Coherus of $0.6 million and $2.0 million recorded in the condensed consolidated balance sheets. As of June 30, 2017 and December 31, 2016, respectively, the Company had, from Coherus, $3.7 million and $6.3 million of Advanced billings and $1.4 million and $3.8 million of Pre-funded study costs, in the condensed consolidated balance sheets.

Xenon Pharmaceuticals, Inc. (“Xenon”)

Certain executives and employees of the Company, including the chief executive officer, have held equity investments in Xenon, a clinical-stage biopharmaceutical company. During the second quarter of 2017, the chief executive officer sold his entire equity position held in Xenon. During July 2015 the Company and Xenon entered into an amended MSA agreement for the Company to provide clinical trial related services. The Company recognized service revenue from Xenon of $0.1 million and $0.1 million during the three months ended June 30, 2017 and 2016, respectively, and service revenue from Xenon of $0.6 million and $0.4 million during the six months ended June 30, 2017 and 2016, respectively, in the Company’s condensed consolidated statements of operations. As of June 30, 2017 and December 31, 2016, respectively, the Company had Accounts receivable and unbilled, net from Xenon of less than $0.1 million and $0.3 million recorded in the condensed consolidated balance sheets. As of June 30, 2017 and December 31, 2016,

- 14 -

respectively, the Company had, from Xenon, $0.4 million and $1.3 million of Advanced billings and $0.1 million and $0.1 million of Pre-funded study costs, in the condensed consolidated balance sheets.

Cymabay Therapeutics, Inc. (“Cymabay”)

Cymabay is a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, including serious rare and orphan disorders. During the first quarter of 2016, it was announced that a Medpace employee would join Cymabay’s board of directors. The Company and Cymabay entered into a MSA dated October 21, 2016. Subsequently, the Company and Cymabay have entered into several task orders for the Company to perform clinical trial related services. During the three months ended June 30, 2017 and 2016, the Company recognized service revenue from Cymabay of $0.2 million and $0.1 million, respectively, and during the six months ended June 30, 2017 and 2016, the Company recognized service revenue from Cymabay of $0.3 million and $0.2 million, respectively, in the Company’s condensed consolidated statements of operations. As of June 30, 2017 and December 31, 2016, respectively, the Company had Accounts receivable and unbilled, net from Cymabay of $0.1 million and less than $0.1 million recorded in the condensed consolidated balance sheets.

LIB Therapeutics LLC (“LIB”)

Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers. The Company entered into a MSA dated November 24, 2015 with LIB, a company that engages in research, development, marketing and commercialization of pharmaceutical drugs. Subsequently, the Company and LIB have entered into several task orders for the Company to perform clinical trial related services. During the three months ended June 30, 2017 and 2016, the Company recognized service revenue from LIB of $0.5 million and less than $0.1 million, respectively, and during the six months ended June 30, 2017 and 2016, the Company recognized service revenue from LIB of $0.6 million and less than $0.1 million, respectively, in the Company’s condensed consolidated statements of operations. As of June 30, 2017 and December 31, 2016, respectively, the Company had Accounts receivable and unbilled, net from LIB of $0.3 million and less than $0.1 million recorded in the condensed consolidated balance sheets.

CinRX Pharma, LLC (“CinRX”)

Certain executives and employees of the Company, including the chief executive officer, are members of CinRX’s board of managers and/or have equity investments in CinRX, a biotech company. The Company and CinRX have entered into several task orders for the Company to perform clinical trial related services. During the three and six months ended June 30, 2017, the Company recognized service revenue from CinRX of $0.2 million, respectively, in the Company’s condensed consolidated statements of operations.

Medpace Investors, LLC

Medpace Investors is a noncontrolling shareholder and related party of Medpace Holdings, Inc. Medpace Investors is owned and managed by employees of the Company. The chief executive officer of Medpace is also the manager and majority unit holder of Medpace Investors. The Company acted as a paying agent for Medpace Investors with taxing authorities principally in instances when employee tax payments or remittance of withholdings related to equity compensation are required. During the three and six months ended June 30, 2016, the Company paid $0.2 million and $0.8 million to various taxing authorities on behalf of Medpace Investors.

Purchase of Real Estate Properties

In December 2016, the Company entered into a purchase agreement for four parcels of real estate property that are closely situated to the Medpace campus in Cincinnati, Ohio, from AT Redevelopment Company, LLC, which is wholly-owned by the Company’s chief executive officer. The purchase price of the real estate property was $0.4 million as determined by an independent third party broker's opinion of value. The transaction closed on January 11, 2017.

Leased Real Estate

Headquarters Lease

The Company entered into an operating lease for its corporate headquarters with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable interest entity because the Company has no direct ownership interest or relationship other than the lease. The lease for headquarters is for an initial term of twelve years through November 2022 with a renewal option for one 10-year term at prevailing market rates. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental rate annually for increases in the consumer price index. Lease expense recognized for each of the three months ended June 30, 2017 and 2016 was $0.6 million, respectively, and lease expense recognized for each of the six months ended June 30, 2017 and 2016 was $1.1 million, respectively. The lease expense was allocated between Direct costs, excluding depreciation and amortization, and Selling, general and administrative in the condensed consolidated statements of operations.

- 15 -

Deemed Assets and Deemed Landlord Liabilities

The Company entered into two multi-year lease agreements governing the occupancy of space of two buildings in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members of his immediate family. In accordance with the accounting guidance related to leases, the Company was deemed in substance to be the owner of the property during the construction phase and at completion. Accordingly, the Company reflected the buildings and related liabilities as deemed assets from landlord building construction in Property and equipment, net, Other current liabilities, and Deemed landlord liability, less current portion, respectively, on the condensed consolidated balance sheets. The Company assumed occupancy in 2012 and the leases expire in 2027 with the Company having one 10-year option to extend the lease term. The deemed assets are being fully depreciated, on a straight line basis, over the 15-year term of the lease. Deemed landlord liabilities are recorded at their net present value when the Company enters into qualifying leases and are reduced as the Company makes periodic lease payments on the properties. Accretion expense is being recorded over the term of the lease as a component of Interest expense, net in the Company’s condensed consolidated statements of operations. The Company paid $1.0 million during the three months ended June 30, 2017 and 2016, respectively, and $1.9 million during the six months ended June 30, 2017 and 2016. The current and long-term portions of the Deemed landlord liability at June 30, 2017 were $1.8 million and $27.6 million, respectively. The current and long-term portions of the Deemed landlord liability at December 31, 2016 were $1.7 million and $28.5 million, respectively. The Company has recognized deemed assets, net of $17.2 million and $18.1 million at June 30, 2017 and December 31, 2016, respectively, in the condensed consolidated balance sheets.

Travel Services

The Company incurs expenses for travel services for company executives provided by a private aviation charter company that is owned by the chief executive officer and the executive vice president of operations of the Company (“private aviation charter”). The Company may contract directly with the private aviation charter for the use of its aircraft or indirectly through a third party aircraft management and jet charter company (the “Aircraft Management Company”). The travel services provided are primarily for business purposes, with certain personal travel paid for as part of the executives’ compensation arrangements. The Aircraft Management Company also makes the private aviation charter aircraft available to third parties. The Company incurred travel expenses of $0.3 million and $0.2 million during the three months ended June 30, 2017 and 2016, respectively, and $0.6 million and $0.5 during the six months ended June 30, 2017 and 2016, respectively, related to these travel services. These travel expenses are recorded in Selling, general and administrative in the Company’s condensed consolidated statements of operations.

(13) Cash Flow Statement- Supplemental Information

During the six months ended June 30, 2017, the Company engaged in the following significant non-cash investing and financing activities:

•

Acquired net assets totaling $0.7 million consisting of net Deferred tax assets of $22.2 million, offset by net Deferred tax liabilities of $0.1 million and Deferred credits of $21.4 million in exchange for Accounts receivable and unbilled, net of $0.6 million and Other assets of $0.1 million.

- 16 -

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our condensed consolidated financial statements and the notes thereto included elsewhere in this Quarterly Report on Form 10-Q, with our audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016 and with the information under the heading “Management Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. This item and the related discussion contain forward-looking statements reflecting current expectations that involve risks and uncertainties. Actual results and the timing of events may differ materially from those indicated in such forward-looking statements. Important factors that may cause such differences include, but are not limited to, those discussed under the “Forward-Looking Statements” below and “Risk Factors” in “Item 1A Risk Factors” of Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts contained herein, including statements regarding our future results of operations and financial position, business strategy, product approvals and plans and our objectives for future operations, are forward looking statements. The words “believe,” “may”, “might”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “seek”, “plan”, “should”, “expect” and similar expressions are intended to identify forward looking statements. Forward looking statements are based largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward looking statements are subject to inherent uncertainties, risks, changes in circumstances and other important factors that are difficult to predict. Moreover, we operate in a very competitive and rapidly changing environment in which new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all important factors on our business or the extent to which any factor, or combination of such factors, may cause actual results to differ materially from those contained in any forward looking statements we may make. In light of these risks, uncertainties and assumptions, the forward looking events and circumstances discussed may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward looking statements. We caution you therefore against relying on these forward looking statements.

We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. For a further discussion of the risks relating to our business, see “Item 1A Risk Factors” of Part I of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Business Overview

We are one of the world’s leading clinical contract research organizations, or CROs, by revenue, solely focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Our mission is to accelerate the global development of safe and effective medical therapeutics. We differentiate ourselves from our competitors by our disciplined operating model centered on providing full-service Phase I-IV clinical development services and our therapeutic expertise. We believe this combination results in timely and cost-effective delivery of clinical development services for our customers. We believe that we are a partner of choice for small- and mid-sized biopharmaceutical companies based on our ability to consistently utilize our full-service, disciplined operating model to deliver timely and high-quality results for our customers.

We focus on conducting clinical trials across all major therapeutic areas, with particular strength in Cardiology, Metabolic Disease, Oncology, Endocrinology, Central Nervous System (“CNS”), Antiviral and Anti-infective (“AVAI”), as well as therapeutic expertise in Medical Devices. Our global platform includes approximately 2,500 employees across 35 countries, providing our customers with broad access to diverse markets and patient populations as well as local regulatory expertise and market knowledge.

Asset Acquisition

- 17 -

How We Generate Revenue

Our revenue consists of net service revenue and reimbursed-out-of-pocket revenue.

Net Service Revenue

We earn customer fees through the performance of services detailed in our customer contracts. Contract scope and pricing is typically based on either a fixed-fee or unit-of-service model and our contracts can range in duration from a few months to several years. These contracts are individually priced and negotiated based on the anticipated project scope, including the complexity of the project and the performance risks inherent in the project. The majority of our contracts are structured with an upfront fee that is collected at the time of contract signing, and the balance of the fee is collected over the duration of the contract either through an arranged billing schedule or upon completion of certain performance targets or defined milestones. This payment structure is standard in the CRO industry.

Net service revenue, which is distinct from billing and cash receipt, is generally recognized based on the proportional performance methodology, which is determined by assessing the proportion of performance completed or delivered to date compared to total specific measures to be delivered or completed under the terms of the contract. The measures utilized to assess performance are specific to the service provided. Net service revenue for unit-of-service contracts is recognized as services are performed or delivered. Cancellation provisions in our contracts allow our customers to terminate a contract either immediately or according to advance notice terms specified within the applicable contract, which is typically 30 days. Contract cancellation may occur for various reasons, including, but not limited to, adverse patient reactions, lack of efficacy, or inadequate patient enrollment. Upon cancellation, we are entitled to fees for services rendered through the date of termination, including payment for subsequent services necessary to conclude the study or close out the contract. These fees are typically subject to negotiation and are realized as net service revenue when collection is reasonably assured. Changes in net service revenue from period to period are driven primarily by new business volume and task order execution activity, project cancellations, and the mix of active studies during a given period that can vary based on therapeutic and or study life cycle stage.

Reimbursed Out-of-Pocket Revenue

Reimbursed out-of-pocket revenue consists primarily of expenses we incur in relation to projects that are reimbursed by our customers with no profit or mark-up. These expenses are defined in our contracts and generally include, but are not limited to, travel, meetings, printing, and shipping and handling fees. Such reimbursements received are included in revenue with the expenditures reflected as a separate component of operating expense. Certain fees paid to investigators and other disbursements in which we act as an agent on behalf of the study sponsor are reflected in the condensed consolidated statements of operations with no resulting effect on our revenue or expenses.

Costs and Expenses

Our costs and expenses are comprised primarily of our direct costs, selling, general and administrative costs, depreciation and amortization and income taxes. In addition, as noted above, we also have reimbursed out-of-pocket expenditures that are directly offset by our reimbursed out-of-pocket revenue.

Direct Costs, Excluding Depreciation and Amortization

Direct costs, excluding depreciation and amortization, are primarily driven by labor and related employee benefits, but also include laboratory supplies and other expenses contributing to service delivery. The other costs of service delivery can include office rent, utilities, supplies and software license expenses, which are allocated between direct costs, excluding depreciation and amortization and selling, general and administrative expenses based on the estimated contribution among service delivery and support function efforts on a percentage basis. Direct costs, excluding depreciation and amortization exclude reimbursed out-of-pocket expenses. Direct costs, excluding depreciation and amortization are expensed as incurred and are not deferred in anticipation of contracts being awarded or finalization of changes in scope. Direct costs, excluding depreciation and amortization as a percentage of net service revenue can vary from period to period due to project labor efficiencies, changes in workforce, compensation/bonus programs and service mix.

- 18 -

Selling, General and Administrative

Selling, general and administrative expenses are primarily driven by compensation and related employee benefits, as well as rent, utilities, supplies, software licenses, professional fees (e.g., legal and accounting expenses), travel, marketing and other operating expenses.

Depreciation

Depreciation is provided on our property and equipment on the straight-line method at rates adequate to allocate the cost of the applicable assets over their estimated useful lives, which is three to five years for computer hardware, software, phone, and medical imaging equipment, five to seven years for furniture and fixtures and other equipment, and thirty to forty years for buildings. Leasehold improvements and deemed assets from landlord building construction are amortized on a straight-line basis over the shorter of the estimated useful life of the improvement or the associated remaining lease term.

Amortization

Amortization relates to finite-lived intangible assets recognized as expense using the straight-line method or using an accelerated method over their estimated useful lives, which range in term from 17 months to 15 years.

Income Tax Provision

Income tax provision consists of federal, state and local taxes on income in multiple jurisdictions. Our income tax is impacted by the pre-tax earnings in jurisdictions with varying tax rates and any related tax credits that may be available to us. Our current and future provision for income taxes will vary from statutory rates due to the impact of valuation allowances in certain countries, income tax incentives, certain non-deductible expenses, and other discrete items.

Key Performance Metrics

To evaluate the performance of our business, we utilize a variety of financial and performance metrics. These key measures include new business awards, cancellations and backlog.

New Business Awards, Cancellations and Backlog

New business awards represent the value of anticipated future net service revenue that has been awarded during the period that is recognized in backlog. This value is recognized upon the signing of a contract or receipt of a written pre-contract confirmation from a customer that confirms an agreement in principle on budget and scope. New business awards also include contract amendments, or changes in scope, where the customer has provided written authorization for changes in budget and scope or has approved us to perform additional work as of the measurement date. Awards may not be recognized as backlog after consideration of a number of factors, including whether (i) the relevant net service revenue is expected only after a pending regulatory hurdle, which might result in cancellation of the study, (ii) the customer funding needed for commencement of the study is not believed to have been secured or (iii) study timelines are uncertain or not well defined. In addition, study amounts that extend beyond a three-year timeline are not included in backlog. The number and amount of new business awards can vary significantly from period to period, and an award’s contractual duration can range from several months to several years based on customer and project specifications.

Cancellations arise in the normal course of business and are reflected when we receive written confirmation from the customer to cease work on a contractual agreement. The majority of our customers can terminate our contracts without cause upon 30 days’ notice. Similar to new business awards, the number and amount of cancellations can vary significantly period over period due to timing of customer correspondence and study-specific circumstances. Total cancellations in a period are offset against gross new business awards received in a period to determine net new business awards in our backlog calculation. Net new business awards were $105.3 million and $111.7 million for the three months ended June 30, 2017 and 2016, respectively, and net new business awards were $199.2 million and $218.1 million for the six months ended June 30, 2017 and 2016, respectively.

Backlog represents anticipated future net service revenue from net new business awards that have not commenced or are currently in process but not complete. Reported backlog will fluctuate based on new business awards, changes in the scope of existing contracts, cancellations, revenue recognition on existing contracts and foreign exchange adjustments from non-U.S. dollar denominated backlog. As of June 30, 2017, our backlog increased by $30.2 million, or 6.5%, to $495.9 million compared to $465.7 million as of June 30, 2016. Included within backlog as of June 30, 2017 was approximately $265 million to $275 million that we expect to convert to net service revenue over the next twelve months, with the remainder expected to convert to net service revenue thereafter.

The effect of foreign currency adjustments on backlog was as follows: favorable foreign currency adjustments of $1.3 million for the three months ended June 30, 2017; favorable foreign currency adjustments of $1.1 million for the six months ended June 30, 2017; unfavorable foreign currency adjustments of $1.4 million for the three months ended June 30, 2016; and unfavorable foreign currency adjustments of $1.4 million for the six months ended June 30, 2016.

- 19 -

Backlog and net new business award metrics may not be reliable indicators of our future period revenue as they are subject to a variety of factors that may cause material fluctuations from period to period. These factors include, but are not limited to, changes in the scope of projects, cancellations, and duration and timing of services provided.

Exchange Rate Fluctuations

The majority of our contracts and operational transactions are U.S. dollar denominated. The Euro represents the largest foreign currency denomination of our contractual and operational exposure. As a result, a portion of our revenue and expenses are subject to exchange rate fluctuations. We have translated the Euro into U.S. dollars using the following average exchange rates based on data obtained from www.xe.com:

	Three Months Ended June 30,				Six Months Ended June 30,
	2017		2016		2017		2016
U.S. Dollars per Euro:		1.10		1.12		1.08		1.11

Results of Operations

Three Months Ended June 30, 2017 compared to Three Months Ended June 30, 2016

	Three Months Ended
	June 30,
(Amounts in thousands, except percentages)	2017			2016			Change			% Change
Service revenue, net	$	94,552		$	92,633		$	1,919			2.1	%
Reimbursed out-of-pocket revenue		11,664			13,321			(1,657	)		(12.4	)%
Total revenue		106,216			105,954			262			0.2	%
Direct costs, excluding depreciation and amortization		51,955			49,234			2,721			5.5	%
Reimbursed out-of-pocket expenses		11,664			13,321			(1,657	)		(12.4	)%
Selling, general and administrative		14,755			14,824			(69	)		(0.5	)%
Depreciation		2,101			1,793			308			17.2	%
Amortization		9,462			12,668			(3,206	)		(25.3	)%
Total operating expenses		89,937			91,840			(1,903	)		(2.1	)%
Income from operations		16,279			14,114			2,165
Miscellaneous expense, net		(125	)		(6	)		(119	)
Interest expense, net		(1,808	)		(5,921	)		4,113
Income before income taxes		14,346			8,187			6,159
Income tax provision		4,793			3,225			1,568
Net income	$	9,553		$	4,962		$	4,591

Six Months Ended June 30, 2017 compared to Six Months Ended June 30, 2016

	Six Months Ended
	June 30,
(Amounts in thousands, except percentages)	2017			2016			Change			% Change
Service revenue, net	$	188,333		$	180,433		$	7,900			4.4	%
Reimbursed out-of-pocket revenue		24,494		$	25,107			(613	)		(2.4	)%
Total revenue		212,827			205,540			7,287			3.5	%
Direct costs, excluding depreciation and amortization		103,060			96,215			6,845			7.1	%
Reimbursed out-of-pocket expenses		24,494			25,107			(613	)		(2.4	)%
Selling, general and administrative		29,909			28,333			1,576			5.6	%
Depreciation		4,231			3,566			665			18.6	%
Amortization		18,910			25,336			(6,426	)		(25.4	)%
Total operating expenses		180,604			178,557			2,047			1.1	%
Income from operations		32,223			26,983			5,240
Miscellaneous expense, net		(497	)		(941	)		444
Interest expense, net		(3,602	)		(11,894	)		8,292
Income before income taxes		28,124			14,148			13,976
Income tax provision		10,124			5,738			4,386
Net income	$	18,000		$	8,410		$	9,590

- 20 -

Service revenue, net and Reimbursed out-of-pocket revenue

For the three months ended June 30, 2017 service revenue, net increased by $1.9 million to $94.6 million, from $92.6 million for the three months ended June 30, 2016. For the six months ended June 30, 2017 service revenue, net increased by $7.9 million to $188.3 million, from $180.4 million. The increase for the three and six months ended June 30, 2017, compared to the same periods in the prior year, were primarily driven by growth within the Oncology and other uncategorized therapeutic areas.

Reimbursed out-of-pocket revenue decreased by $1.7 million to $11.7 million for the three months ended June 30, 2017, from $13.3 million for the three months ended June 30, 2016. Reimbursed out-of-pocket revenue decreased by $0.6 million to $24.5 million for the six months ended June 30, 2017, from $25.1 million for the six months ended June 30, 2016. Reimbursed out-of-pocket revenues can fluctuate significantly from period to period based on the timing of program initiation or closeout, and these changes do not necessarily correlate to changes in net service revenue. The reimbursements were offset by an equal amount of reimbursed out-of-pocket expenses.

Direct costs, excluding depreciation and amortization and Reimbursed out-of-pocket expenses

Our direct costs, excluding depreciation and amortization increased by $2.7 million, to $52.0 million for the three months ended June 30, 2017 from $49.2 million for the three months ended June 30, 2016. Our direct costs, excluding depreciation and amortization increased by $6.8 million, to $103.1 million for the six months ended June 30, 2017 from $96.2 million for the six months ended June 30, 2016. The increase was primarily attributed to increases in employee related costs for additional personnel, lab related costs and office rent to support the growth in service activities. The employee related costs portion of direct costs, excluding depreciation and amortization increased by $1.7 million and $5.4 million for the three and six months ended June 30, 2017, compared to the same period in the prior year. Lab related costs increased by $0.5 million for the three months ended June 30, 2017 and remained relatively consistent for the six months ended June 30, 2017, compared to the same periods in the prior year. Office rent costs increased by $0.2 and $0.5 million for the three and six months ended June 30, 2017, compared to the same periods in the prior year.

Selling, general and administrative

Selling, general and administrative expenses decreased by $0.1 million, to $14.8 million for the three months ended June 30, 2017 from $14.8 million for the three months ended June 30, 2016. Selling, general and administrative expenses increased by $1.6 million, to $29.9 million for the six months ended June 30, 2017 from $28.3 million for the six months ended June 30, 2016. This decrease for the three months ended June 30, 2017 was primarily driven by a reduction in bad debt expense of $1.2 million due primarily to net bad debt recoveries for the three months ended June 30, 2017, compared to bad debt expense in the same period in the prior year. This was partially offset by an increase in employee related costs for additional personnel of $0.8 million for the three months ended June 30, 2017, compared to the same period in the prior year. This increase for the six months ended June 30, 2017 was primarily driven by an increase in employee related costs for additional personnel of $2.5 million, compared to the same period in the prior year. This was offset by a reduction in bad debt expense of $1.3 million due primarily to net bad debt recoveries for the six months ended June 30, 2017, compared to bad debt expense in the same period in the prior year.

Depreciation and Amortization

Depreciation and amortization expense decreased by $2.9 million, to $11.6 million for the three months ended June 30, 2017 from $14.5 million for the three months ended June 30, 2016. Depreciation and amortization expense decreased by $5.8 million, to $23.1 million for the six months ended June 30, 2017 from $28.9 million for the six months ended June 30, 2016. The decrease in depreciation and amortization were primarily related to the continued amortization of our definite lived intangible assets, which are amortized on an accelerated basis.

Miscellaneous expense, net

Miscellaneous expense, net increased by $0.1 million to $0.1 million of expense for the three months ended June 30, 2017 from $0.0 million of expense for the three months ended June 30, 2016. Miscellaneous expense, net decreased by $0.4 million to $0.5 million of expense for the six months ended June 30, 2017 from $0.9 million of expense for the six months ended June 30, 2016. The change for the six months ended June 30, 2017 was mainly attributable to foreign exchange gains or losses that arise in connection with the revaluation of short-term intercompany balances between our domestic and international subsidiaries, gains or losses from foreign currency transactions, such as those resulting from the settlement of third-party accounts receivables and payables denominated in a currency other than the local currency of the entity making the payment and exit costs related to the previous headquarter lease.

Interest expense, net

Interest expense, net decreased by $4.1 million to $1.8 million for the three months ended June 30, 2017 from $5.9 million for the three months ended June 30, 2016. Interest expense, net decreased by $8.3 million to $3.6 million for the six months ended June 30, 2017 from $11.9 million for the six months ended June 30, 2016. The decrease in interest expense, net was related to the average

- 21 -

lower outstanding balance under our Senior Secured Term Loan Facility (as defined below), as well as a lower effective interest rate as a result of the new credit agreement entered into in December 2016 (as described below).

Income tax provision

Income tax provision increased by $1.6 million, to $4.8 million for the three months ended June 30, 2017 from $3.2 million for the three months ended June 30, 2016. Income tax provision increased by $4.4 million, to $10.1 million for the six months ended June 30, 2017 from $5.7 million for the six months ended June 30, 2016. The overall effective tax rate for the three months ended June 30, 2017 was 33.4%, compared to an overall effective tax rate of 39.4% for the three months ended June 30, 2016. The overall effective tax rate for the six months ended June 30, 2017 was 36.0%, compared to an overall effective tax rate of 40.6% for the six months ended June 30, 2016. The change in effective tax rates and the increase in income tax provision was primarily due to the increases in projected pre-tax book income for the three and six months ended June 30, 2017 partially offset with a favorable impact associated with domestic uncertain tax positions and the favorable tax impact associated with acquired tax attributes.

- 22 -

Liquidity and Capital Resources

We assess our liquidity in terms of our ability to generate cash to fund our operating, investing and financing activities. Our principal sources of liquidity are operating cash flows and funds available for borrowing under our Senior Secured Revolving Credit Facility (as defined below). As of June 30, 2017, we had cash and cash equivalents of $29.3 million, including approximately $0.3 million of restricted cash, primarily related to advanced payments received pursuant to certain sponsor contracts. Approximately $9.3 million of cash and cash equivalents, none of which was restricted, was held by our foreign subsidiaries as of June 30, 2017. On December 8, 2016, the Company entered into a credit agreement (the “Senior Secured Credit Agreement”) consisting of a $165.0 million term loan (the “Senior Secured Term Loan Facility”) and a $150.0 million revolving credit facility (the “Senior Secured Revolving Credit Facility” and, together with the Senior Secured Term Loan Facility, the “Senior Secured Credit Facilities”). As of June 30, 2017, we had $149.8 million available for borrowing under our Senior Secured Revolving Credit Facility. Our expected primary cash needs on both a short and long-term basis are for investment in operational growth, capital expenditures, payment of debt, share repurchases, selective strategic bolt-on acquisitions, other investments, and other general corporate needs for the next 12 months and on a longer-term basis. We have historically funded our operations and growth with cash flow from operations and borrowings under our credit facilities. We expect to continue expanding our operations through organic growth and potentially highly selective bolt-on acquisitions and investments. We expect these activities will be funded from existing cash, cash flow from operations and, if necessary, borrowings under our existing or future credit facilities. We have deemed that foreign earnings will be indefinitely reinvested and therefore we have not provided taxes on these earnings. While we do not anticipate the need to repatriate these foreign earnings for liquidity purposes given our cash flows from operations and available borrowings under existing and future credit facilities, we would incur taxes on these earnings if the need for repatriation due to liquidity purposes arises. We believe that our sources of liquidity and capital will be sufficient to finance our cash needs for the next 12 months and on a longer-term basis. However, we cannot assure you that our business will generate sufficient cash flow from operations, or that future borrowings will be available to us under our Senior Secured Credit Facilities or otherwise, in an amount sufficient to fund our liquidity needs. If our cash flows and capital resources are insufficient to service our indebtedness, we may be forced to reduce or delay capital expenditures, sell assets, seek additional capital or restructure or refinance our indebtedness. These alternative measures may not be successful and may not permit us to meet our scheduled debt service obligations. Our ability to restructure or refinance our debt will depend on the condition of the capital markets and our financial condition at such time. Any refinancing of our debt could be at higher interest rates and may require us to comply with more onerous covenants, which could further restrict our business operations. In addition, the terms of existing or future debt agreements may restrict us from adopting some of these alternatives. In the absence of such operating results and resources, we could face substantial liquidity problems and might be required to dispose of material assets or operations to meet our debt service and other obligations. We may not be able to consummate those dispositions for fair market value or at all, and any proceeds that we could realize from any such dispositions may not be adequate to meet our debt service obligations then due. See “Risk Factors—Risks Relating to our Indebtedness—We may not be able to generate sufficient cash to service all of our indebtedness, and may be forced to take other actions to satisfy our obligations under our indebtedness that may not be successful” in Item 1A of Part I of the 2016 Annual Report on Form 10-K.




	Six			Six
	Months			Months
	Ended			Ended
	June 30,			June 30,
Cash Flows (Amounts in thousands)	2017			2016
Net cash provided by operating activities	$	29,733		$	20,491
Net cash used in investing activities		(6,505	)		(5,653	)
Net cash used in financing activities		(32,450	)		(15,678	)
Effect of exchange rates on cash, cash equivalents and restricted cash		1,145			143
Decrease in cash, cash equivalents and restricted cash	$	(8,077	)	$	(697	)

Cash Flow from Operating Activities

Cash flows from operations are driven mainly by net income and net movement in accounts receivable and unbilled, net, advanced billings, pre-funded liabilities, accounts payable, accrued expenses, deferred taxes and deferred credits. Accounts receivable and unbilled, net, advanced billings and pre-funded liabilities fluctuate on a regular basis as we perform our services, bill our customers and ultimately collect on those receivables. We attempt to negotiate payment terms in order to provide for payments prior to or soon after the provision of services, but this timing of collection can vary significantly on a period by period comparative basis.

Net cash flows provided by operating activities was $29.7 million for the six months ended June 30, 2017 beginning with net income of $18.0 million. Adjustments to reconcile net income to net cash provided by operating activities were $24.1 million, primarily related to amortization of intangibles of $18.9 million, depreciation of $4.2 million and stock based compensation expense of $2.2

- 23 -

million, offset by $0.9 million of benefit from deferred taxes. Changes in operating assets and liabilities used $12.4 million in operating cash flows and was primarily driven by decreased accrued expenses of $8.4 million, decreased accounts payable of $2.9 million and decreased pre-funded study costs of $3.5 million offset by decreased accounts receivable and unbilled, net of $3.4 million.

Net cash flows provided by operating activities was $20.5 million for the six months ended June 30, 2016 beginning with net income of $8.4 million. Adjustments to reconcile net income to net cash provided by operating activities were $33.8 million primarily related to amortization of intangibles of $25.3 million, depreciation of $3.6 million and stock based compensation expense of $4.3 million. Changes in operating assets and liabilities used $21.7 million in operating cash flows and was primarily driven by increased accounts receivable and unbilled services, net of $24.8 million, increased prepaid expenses and other assets of $8.5 million primarily related to federal tax payments and decreased accounts payable of $2.1 million, offset by increased pre funded study costs of $2.4 million and advanced billings of $15.0 million.

Cash Flow from Investing Activities

Net cash used in investing activities was $6.5 million for the six months ended June 30, 2017 primarily consisting of property and equipment expenditures and an acquisition of intangible assets.

Net cash used in investing activities was $5.7 million for the six months ended June 30, 2016 primarily consisting of property and equipment expenditures.

Cash Flow from Financing Activities

Net cash used in financing activities was $32.5 million for the six months ended June 30, 2017 primarily related to $26.4 million in repurchases of common stock and $6.2 million in principal payments on our Senior Secured Term Loan Facility.

Net cash used in financing activities was $15.7 million for the six months ended June 30, 2016, primarily consisting of $15.0 million principal payment on our Senior Secured Term Loan Facility.

Share Repurchases

In April 2017, the Board of the Company authorized a share repurchase program with an authorized level of $50.0 million. The share repurchase program, according to its terms, will expire in April 2018. Repurchases under the repurchase program may take place in the open market or negotiated transactions, at the discretion of the Company’s management. During the three and six months ended June 30, 2017, the Company repurchased 1,042,455 shares of its outstanding common stock.

Indebtedness

As of June 30, 2017, we had total indebtedness of $158.8 million, substantially all of which was attributed to outstanding borrowings on the Senior Secured Term Loan Facility. There were $0.2 million in outstanding borrowings under the Senior Secured Revolving Credit Facility as of June 30, 2017. As of June 30, 2017, we had $0.3 million in letters of credit outstanding related to certain operating lease obligations, which are secured by the Senior Secured Revolving Credit Facility. See Note 8 to our audited consolidated financial statements on our Annual Report on Form 10-K for details regarding our Senior Secured Credit Facilities.

Contractual Obligations and Commercial Commitments

We have various contractual obligations, which are recorded as liabilities in our condensed consolidated financial statements. Other items, such as operating lease obligations, are not recognized as liabilities in our condensed consolidated financial statements but are required to be disclosed.

There have been no material changes, outside of the ordinary course of business, to our contractual obligations as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Off-Balance Sheet Arrangements

Off balance sheet arrangements refer to any transaction, agreement or other contractual arrangement to which an entity not consolidated under our entity structure exists, where we have an obligation arising under a guarantee contract, derivative instrument or variable interest or a retained or contingent interest in assets transferred to such an entity or similar arrangement that serves as credit, liquidity or market risk support for such assets. We have no off balance sheet arrangements currently.

- 24 -

Critical Accounting Policies and Estimates

The preparation of financial statements in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP, requires us to make a variety of decisions which affect reported amounts and related disclosures, including the selection of appropriate accounting principles and the assumptions on which to base accounting estimates. In reaching such decisions, we apply judgment based on our understanding and analysis of the relevant circumstances, including our historical experience and other assumptions. Actual results could differ from our estimates. We are committed to incorporating accounting principles, assumptions and estimates that promote the representational faithfulness, verifiability, neutrality and transparency of the accounting information included in the financial statements.

There have been no significant changes in the critical accounting policies and estimates as previously described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Recently Adopted Accounting Standards

•

- 25 -

as an operating activity. The Company elected to adopt this portion of the standard on a prospective basis beginning in 2017. Prior periods have not been adjusted.

•

Upon adoption, no other aspects of ASU 2016-09 had an effect on the Company's condensed consolidated financial statements or related footnote disclosures.

Recently Issued Accounting Standards

Agent Considerations (Reporting Revenue Gross versus Net). In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. In May 2016, the FASB issued ASU 2016-12, Narrow-Scope Improvements and Practical Expedients. In December 2016, the FASB issued ASU 2016-20 Technical Corrections and Improvements to Topic 606, Revenue From Contracts with Customers. ASUs’ 2016-20, 2016-12, 2016-10 and 2016-08 all clarify the interpretation guidance in ASU No. 2014-09, “Revenue from Contracts with Customers” specifically related to narrowing specific aspects of Topic 606 and adding illustrative examples to assist in the application of the guidance. The effective date and transition requirements in ASUs’ 2016-20, 2016-12, 2016-10, and 2016-08 are the same as the effective date and transition requirements of ASU 2014-09. ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, deferred the original effective date of ASU 2014-09 by one year. The new standard allows for either a retrospective or modified retrospective approach to transition upon adoption. The new standard will be effective for annual reporting periods beginning after December 15, 2017. Early adoption is permitted for annual reporting periods beginning after December 15, 2016.

There have been no significant changes in the critical accounting policies and estimates as previously described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes to our quantitative and qualitative disclosures about market risk as compared to the quantitative and qualitative disclosures about market risk described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Item 4. Controls and Procedures

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating our disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

- 26 -

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer, evaluated, as of the end of the period covered by this Quarterly Report on Form 10-Q, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2017.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control performed during the fiscal quarter ended June 30, 2017, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

We are party to legal proceedings incidental to our business. While the outcome of these matters could differ from management’s expectations, we do not believe that the resolution of these matters is reasonably likely to have a material adverse effect to our financial statements.

Item 1A. Risk Factors

For a discussion of our potential risks and uncertainties, see the information under the heading “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. There have been no significant changes from the risk factors previously disclosed in our Annual Report, except as noted below.

Risks Relating to Ownership of Our Common Stock

Investment funds affiliated with Cinven pledged all of its owned shares of our common stock as collateral for borrowings under a credit agreement unaffiliated with Medpace.

On June 16, 2017, Cinven informed us that Medpace Limited Partnership (“MLP”), an entity formed by Cinven to hold all Cinven’s equity interests in us, entered into a credit agreement (the “MLP Credit Agreement”) with Credit Suisse AG, Cayman Islands Branch, and Morgan Stanley Bank, N.A., as lenders (together, the “Lenders”), Credit Suisse AG, Cayman Islands Branch, as administrative agent, and Credit Suisse Securities (USA) LLC, as calculation agent. Pursuant to the MLP Credit Agreement, MLP entered into a pledge agreement (the “MLP Pledge Agreement”) with Credit Suisse Securities (USA) LLC, as secured party and Morgan Stanley Bank, N.A., as secured party (together, the “Secured Parties”). Pursuant to the MLP Pledge Agreement, MLP pledged all of its shares of the Company’s common stock, $0.01 par value per share, to the Secured Parties.

On June 21, 2017 (the “MLP Funding Date”), MLP borrowed $150.0 million under the MLP Credit Agreement. Pursuant to the MLP Pledge Agreement, to secure any borrowings under the MLP Credit Agreement, MLP pledged 22,999,997 shares (collectively, the “MLP Pledged Shares”) of the Company’s common stock as of the MLP Funding Date. The MLP Pledged Shares represented approximately 56.4% of the Company’s issued and outstanding Common Stock as of June 21, 2017. All of the MLP Pledged Shares were contributed to MLP from Cinven’s Fifth Cinven Fund (No. 1) Limited Partnership, Fifth Cinven Fund (No. 2) Limited Partnership, Fifth Cinven Fund (No. 3) Limited Partnership, Fifth Cinven Fund (No. 4) Limited Partnership, Fifth Cinven Fund (No. 5) Limited Partnership, Fifth Cinven Fund (No. 6) Limited Partnership, Fifth Cinven Fund FCP-SIF and Fifth Cinven Fund Co-Investment Partnership, which collectively own all of the equity interest in MLP.

The MLP Credit Agreement contains customary default provisions. In the event of a default under the MLP Credit Agreement by MLP, the Lenders and their affiliates and assignees may foreclose upon any and all MLP Pledged Shares and may seek recourse against MLP. The Company is not a party to the MLP Credit Agreement or the MLP Pledge Agreement and has no obligations thereunder, but has delivered a letter agreement to the Lenders in which it has, among other things, agreed, subject to applicable law and stock exchange rules, not to take any action intended to hinder or delay the exercise of any remedies by the Lenders under the MLP Credit Agreement or the MLP Pledge Agreement.

In the event of a foreclosure upon any or all of the MLP Pledged Shares, we may no longer be a controlled company, and we may have difficulties complying with certain NASDAQ rules that we take advantage of as a controlled company if we cease to be a controlled company. We intend to comply with these NASDAQ rules if we cease to be a controlled company. However, there can be no assurance that we will be able to comply with such rules before the end of the applicable phase-in period for compliance. See “Risk Factors—Risks Relating to Ownership of Our Common Stock—We are a “controlled company” within the meaning of the NASDAQ rules and, as a result, we qualify for, and rely on, exemptions from certain corporate governance requirements. Our

- 27 -

shareholders do not have the same protections afforded to shareholders of companies that are subject to such requirements” in Item 1A of Part I of the Annual Report on Form 10-K filed on February 28, 2017 for the year ended December 31, 2016. Additionally, any foreclosure upon the MLP Pledged Shares could result in sales of a substantial amount of shares of our common stock in the public market, which could cause the market price of our common stock to drop significantly, even if our business is doing well. See “Risk Factors—Risks Relating to Ownership of Our Common Stock—Shares of our common stock may be sold into the market in the near future. This could cause the market price of our common stock to drop significantly, even if our business is doing well” in Item 1A of Part I of the Annual Report on Form 10-K. Moreover, the occurrence of a foreclosure, and a subsequent sale of all, or substantially all, of the MLP Pledged Shares could result in a change of control under our Senior Secured Credit Facilities, even when such change may not be in the best interest of our stockholders. Such sale of the MLP Pledged Shares may also result in another shareholder beneficially owning a significant amount of our common stock and being able to exert a significant degree of influence or actual control over our management and affairs. Such shareholder’s interests may be different from or conflict with those of our other shareholders. See “Risk Factors—Risks Relating to Ownership of Our Common Stock—Cinven and our Chief Executive Officer and founder collectively control a substantial majority of our outstanding common stock and their interests may be different from or conflict with those of our other shareholders” in Item 1A of Part I of the Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities, and Use of Proceeds

Share Repurchases

This table provides certain information with respect to our purchases of shares of the Company’s common stock during the second fiscal quarter of 2017:

Issuer’s Purchases of Equity Securities (a)

Period	Total Number of Shares Purchased		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publically Announced Plan		Approximate Dollar Value of Share That May Yet Be Purchased Under the Plan
May 4, 2017, through May 31, 2017		883,600	$	24.83		883,600	$	28,057,690
June 1, 2017, through June 30, 2017		158,855	$	27.87		158,855	$	23,630,685
Total		1,042,455	$	25.30		1,042,455

(a)

On May 1, 2017 the Company announced that its Board of Directors had authorized a share repurchase program (“2017 Repurchase Plan”) of up to $50 million of the Company’s common stock in the open market or negotiated transactions, at the discretion of our management. The 2017 Repurchase Plan expires when the entire $50 million repurchase is exhausted or on April 1, 2018, whichever occurrence first occurs. The Company has not repurchased any common shares other than those made through the publically announced 2017 Repurchase Plan.

Recent Sales of Unregistered Securities

On January 10, 2017, an employee exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 1,851 shares of our common stock at a price of $16.21 per share for an aggregate purchase price of approximately $30,000.

On February 2, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a 925 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $13,300 and 277 shares of our common stock at a price of $16.21 per share for an aggregate purchase price of approximately $4,500.

On February 10, 2017, an employee exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 1,000 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $14,400.

On February 15, 2017, an employee exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 1,851 shares of our common stock at a price of $16.21 per share for an aggregate purchase price of approximately $30,000.

On February 21, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a 1,500 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $21,600 and 462 shares of our common stock at a price of $16.89 per share for an aggregate purchase price of approximately $7,800.

On February 28, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a 2,555 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $36,800 and 832 shares of our common stock at a price of $16.21 per share for an aggregate purchase price of approximately $13,500.

- 28 -

On March 2, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a 1,185 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $17,100 and 250 shares of our common stock at a price of $16.21 per share for an aggregate purchase price of approximately $4,100.

On April 1, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 8,154 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $117,500.

On April 5, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 370 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $5,300 and 1,851 shares of our common stock at a price of $18.23 per share for an aggregate purchase price of approximately $33,700.

On April 6, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 648 shares of our common stock at a price of $16.21 per share for an aggregate purchase price of approximately $10,500.

On May 2, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 11,648 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $167,800, 4,259 shares of our common stock at a price of $16.21 per share for an aggregate purchase price of approximately $69,000 and 2,222 shares of our common stock at a price of $16.88 per share for an aggregate purchase price of approximately $37,500.

On May 5, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 9,260 shares of our common stock at a price of $16.21 per share for an aggregate purchase price of approximately $150,100.

On May 24, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 2,777 shares of our common stock at a price of $16.21 per share for an aggregate purchase price of approximately $45,000.

On June 12, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 6,666 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $96,100 and 1,851 shares of our common stock at a price of $16.20 per share for an aggregate purchase price of approximately $30,000.

On June 23, 2017, employees exercised stock options granted under the 2014 Equity Incentive Plan to purchase a total of 8,334 shares of our common stock at a price of $14.41 per share for an aggregate purchase price of approximately $120,100 and 1,851 shares of our common stock at a price of $16.20 per share for an aggregate purchase price of approximately $30,000.

Use of Proceeds from Registered Securities

Not applicable.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

The exhibits in the accompanying Exhibit Index following the signature page are filed or furnished as a part of this report and are incorporated herein by reference.

- 29 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	MEDPACE HOLDINGS, INC.

	/s/ Jesse J. Geiger
	Jesse J. Geiger
	Chief Financial Officer, and Chief Operating Officer, Laboratory Operations (Authorized Officer and Principal Financial Officer)

Date: August 1, 2017

- 30 -

EXHIBIT INDEX

Incorporated by Reference

Exhibit
Number

Exhibit Description

Form

File No.

Exhibit

Filing
Date

Filed/
Furnished
Herewith

31.1

Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer

31.2

Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer

32.1

Section 1350 Certification of Chief Executive Officer

32.2

Section 1350 Certification of Chief Financial Officer

101.INS

XBRL Instance Document

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation

*	Filed herewith.

**	Furnished herewith.

- 31 -

EX-31.1 2 medp-ex311_7.htm EX-31.1 medp-ex311_7.htm

Exhibit 31.1

I, Dr. August J. Troendle, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Medpace Holdings, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

[Omitted];

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2017

/s/ August J. Troendle

Dr. August J. Troendle

President, Chief Executive Officer and Chairman of the Board of Directors

(Principal Executive Officer)

EX-31.2 3 medp-ex312_8.htm EX-31.2 medp-ex312_8.htm

Exhibit 31.2

I, Jesse Geiger, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q of Medpace Holdings, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

[Omitted];

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 1, 2017

/s/ Jesse Geiger

Jesse Geiger

Chief Financial Officer and Chief Operating Officer, Laboratory Operations

(Principal Financial Officer)

EX-32.1 4 medp-ex321_9.htm EX-32.1 medp-ex321_9.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Medpace Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2017 filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dr. August J. Troendle, President, Chief Executive Officer and Chairman of the Board of Directors of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

•

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

•

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date: August 1, 2017

By:		/s/ August J. Troendle
		Dr. August J. Troendle
		President, Chief Executive Officer and Chairman of the Board of Directors
		(Principal Executive Officer)

EX-32.2 5 medp-ex322_6.htm EX-32.2 medp-ex322_6.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Medpace Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2017 filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jesse Geiger, Chief Financial Officer and Chief Operating Officer, Laboratory Operations of the Company, do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

•

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

•

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.

Date: August 1, 2017

By:		/s/ Jesse Geiger
		Jesse Geiger
		Chief Financial Officer and Chief Operating Officer, Laboratory Operations
		(Principal Financial Officer)

EX-101.INS 6 medp-20170630.xml XBRL INSTANCE DOCUMENT shares iso4217:USD iso4217:USD shares pure medp:Parcel medp:RenewalOption medp:Agreement medp:Building 0001668397 2017-01-01 2017-06-30 0001668397 2017-07-28 0001668397 2017-06-30 0001668397 2016-12-31 0001668397 2017-04-01 2017-06-30 0001668397 2016-04-01 2016-06-30 0001668397 2016-01-01 2016-06-30 0001668397 2015-12-31 0001668397 2016-06-30 0001668397 us-gaap:MaximumMember 2017-04-30 0001668397 2017-04-01 2017-04-30 0001668397 us-gaap:AccountingStandardsUpdate201609Member us-gaap:MaximumMember 2017-01-01 2017-06-30 0001668397 medp:NephroGenexIncMember 2017-05-01 2017-05-31 0001668397 medp:NephroGenexIncMember 2017-05-31 0001668397 us-gaap:CommonStockMember 2017-04-01 2017-06-30 0001668397 us-gaap:CommonStockMember 2016-04-01 2016-06-30 0001668397 us-gaap:CommonStockMember 2017-01-01 2017-06-30 0001668397 us-gaap:CommonStockMember 2016-01-01 2016-06-30 0001668397 us-gaap:RestrictedStockMember 2017-04-01 2017-06-30 0001668397 us-gaap:RestrictedStockMember 2016-04-01 2016-06-30 0001668397 us-gaap:RestrictedStockMember 2017-01-01 2017-06-30 0001668397 us-gaap:RestrictedStockMember 2016-01-01 2016-06-30 0001668397 us-gaap:EmployeeStockOptionMember 2017-04-01 2017-06-30 0001668397 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-06-30 0001668397 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-06-30 0001668397 medp:BacklogMember 2017-06-30 0001668397 medp:BacklogMember 2016-12-31 0001668397 us-gaap:CustomerRelationshipsMember 2017-06-30 0001668397 us-gaap:CustomerRelationshipsMember 2016-12-31 0001668397 us-gaap:DevelopedTechnologyRightsMember 2017-06-30 0001668397 us-gaap:DevelopedTechnologyRightsMember 2016-12-31 0001668397 us-gaap:OtherIntangibleAssetsMember 2017-06-30 0001668397 us-gaap:OtherIntangibleAssetsMember 2016-12-31 0001668397 medp:TwoThousandSixteenIncentiveAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2017-04-01 2017-06-30 0001668397 medp:TwoThousandSixteenIncentiveAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2017-01-01 2017-06-30 0001668397 medp:TwoThousandSixteenIncentiveAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember medp:NonEmployeeDirectorsMember 2017-04-01 2017-06-30 0001668397 medp:TwoThousandSixteenIncentiveAwardPlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember medp:NonEmployeeDirectorsMember 2017-01-01 2017-06-30 0001668397 medp:TwoThousandFourteenEquityIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2016-01-01 2016-06-30 0001668397 medp:TwoThousandFourteenEquityIncentivePlanMember us-gaap:RestrictedStockMember 2016-01-01 2016-06-30 0001668397 us-gaap:RestrictedStockMember 2016-12-31 0001668397 us-gaap:RestrictedStockMember 2017-06-30 0001668397 medp:DirectCostsExcludingDepreciationAndAmortizationMember 2017-04-01 2017-06-30 0001668397 medp:DirectCostsExcludingDepreciationAndAmortizationMember 2016-04-01 2016-06-30 0001668397 medp:DirectCostsExcludingDepreciationAndAmortizationMember 2017-01-01 2017-06-30 0001668397 medp:DirectCostsExcludingDepreciationAndAmortizationMember 2016-01-01 2016-06-30 0001668397 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-04-01 2017-06-30 0001668397 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-04-01 2016-06-30 0001668397 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-06-30 0001668397 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-06-30 0001668397 medp:EmployeeLoansMember 2017-06-30 0001668397 medp:EmployeeLoansMember us-gaap:OtherNoncurrentAssetsMember 2016-12-31 0001668397 medp:CinvenCapitalManagementVGeneralPartnerLimitedMember 2016-04-01 2016-06-30 0001668397 medp:CinvenCapitalManagementVGeneralPartnerLimitedMember 2016-01-01 2016-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:SymplmedPharmaceuticalsLLCMember us-gaap:MaximumMember 2017-04-01 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:SymplmedPharmaceuticalsLLCMember us-gaap:MaximumMember 2016-04-01 2016-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:SymplmedPharmaceuticalsLLCMember us-gaap:MaximumMember 2017-01-01 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:SymplmedPharmaceuticalsLLCMember 2016-01-01 2016-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CoherusBioSciencesIncMember 2017-04-01 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CoherusBioSciencesIncMember 2016-04-01 2016-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CoherusBioSciencesIncMember 2017-01-01 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CoherusBioSciencesIncMember 2016-01-01 2016-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CoherusBioSciencesIncMember 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CoherusBioSciencesIncMember 2016-12-31 0001668397 medp:XenonClinicalBiopharmaceuticalCompanyMember medp:RelatedPartyServiceAgreementsMember 2017-04-01 2017-06-30 0001668397 medp:XenonClinicalBiopharmaceuticalCompanyMember medp:RelatedPartyServiceAgreementsMember 2016-04-01 2016-06-30 0001668397 medp:XenonClinicalBiopharmaceuticalCompanyMember medp:RelatedPartyServiceAgreementsMember 2017-01-01 2017-06-30 0001668397 medp:XenonClinicalBiopharmaceuticalCompanyMember medp:RelatedPartyServiceAgreementsMember 2016-01-01 2016-06-30 0001668397 medp:XenonClinicalBiopharmaceuticalCompanyMember medp:RelatedPartyServiceAgreementsMember us-gaap:MaximumMember 2017-06-30 0001668397 medp:XenonClinicalBiopharmaceuticalCompanyMember medp:RelatedPartyServiceAgreementsMember 2016-12-31 0001668397 medp:XenonClinicalBiopharmaceuticalCompanyMember medp:RelatedPartyServiceAgreementsMember 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CymabayTherapeuticsCompanyMember 2017-04-01 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CymabayTherapeuticsCompanyMember 2016-04-01 2016-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CymabayTherapeuticsCompanyMember 2017-01-01 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CymabayTherapeuticsCompanyMember 2016-01-01 2016-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CymabayTherapeuticsCompanyMember 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CymabayTherapeuticsCompanyMember us-gaap:MaximumMember 2016-12-31 0001668397 medp:RelatedPartyServiceAgreementsMember medp:LIBTherapeuticsLLCMember 2017-04-01 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:LIBTherapeuticsLLCMember us-gaap:MaximumMember 2016-04-01 2016-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:LIBTherapeuticsLLCMember 2017-01-01 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:LIBTherapeuticsLLCMember us-gaap:MaximumMember 2016-01-01 2016-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:LIBTherapeuticsLLCMember 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:LIBTherapeuticsLLCMember us-gaap:MaximumMember 2016-12-31 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CinRXPharmaLLCMember 2017-04-01 2017-06-30 0001668397 medp:RelatedPartyServiceAgreementsMember medp:CinRXPharmaLLCMember 2017-01-01 2017-06-30 0001668397 medp:MedpaceInvestorsLLCMember 2016-04-01 2016-06-30 0001668397 medp:MedpaceInvestorsLLCMember 2016-01-01 2016-06-30 0001668397 us-gaap:ChiefExecutiveOfficerMember medp:PurchaseOfRealEstatePropertiesMember 2016-12-31 0001668397 us-gaap:ChiefExecutiveOfficerMember medp:PurchaseOfRealEstatePropertiesMember 2017-01-01 2017-06-30 0001668397 medp:LeasedRealEstateMember us-gaap:ChiefExecutiveOfficerMember 2017-01-01 2017-06-30 0001668397 medp:LeasedRealEstateMember us-gaap:ChiefExecutiveOfficerMember 2016-01-01 2016-06-30 0001668397 medp:LeasedRealEstateMember us-gaap:ChiefExecutiveOfficerMember 2017-04-01 2017-06-30 0001668397 medp:LeasedRealEstateMember us-gaap:ChiefExecutiveOfficerMember 2016-04-01 2016-06-30 0001668397 medp:LeasedRealEstateMember medp:ChiefExecutiveOfficerAndImmediateFamilyMember 2017-01-01 2017-06-30 0001668397 medp:LeasedRealEstateMember medp:ChiefExecutiveOfficerAndImmediateFamilyMember 2016-01-01 2016-06-30 0001668397 medp:LeasedRealEstateMember medp:ChiefExecutiveOfficerAndImmediateFamilyMember 2017-04-01 2017-06-30 0001668397 medp:LeasedRealEstateMember medp:ChiefExecutiveOfficerAndImmediateFamilyMember 2016-04-01 2016-06-30 0001668397 medp:LeasedRealEstateMember medp:ChiefExecutiveOfficerAndImmediateFamilyMember 2017-06-30 0001668397 medp:LeasedRealEstateMember medp:ChiefExecutiveOfficerAndImmediateFamilyMember 2016-12-31 0001668397 us-gaap:BuildingMember medp:PropertyAndEquipmentNetMember medp:LeasedRealEstateMember medp:ChiefExecutiveOfficerAndImmediateFamilyMember 2017-06-30 0001668397 us-gaap:BuildingMember medp:PropertyAndEquipmentNetMember medp:LeasedRealEstateMember medp:ChiefExecutiveOfficerAndImmediateFamilyMember 2016-12-31 0001668397 medp:TravelServicesMember us-gaap:ChiefExecutiveOfficerMember 2017-04-01 2017-06-30 0001668397 medp:TravelServicesMember us-gaap:ChiefExecutiveOfficerMember 2016-04-01 2016-06-30 0001668397 medp:TravelServicesMember us-gaap:ChiefExecutiveOfficerMember 2017-01-01 2017-06-30 0001668397 medp:TravelServicesMember us-gaap:ChiefExecutiveOfficerMember 2016-01-01 2016-06-30 10-Q false 2017-06-30 2017 Q2 MEDP Medpace Holdings, Inc. 0001668397 --12-31 Non-accelerated Filer 39486848

29055000

37099000

275000

308000

76664000

79767000

17129000

16074000

123123000

133248000

45244000

43805000

660981000

117676000

136071000

11536000

97000

5086000

4903000

963646000

979105000

7195000

10911000

16392000

24417000

48530000 51948000

65577000

65668000

14438000

12375000

3130000

3284000

155262000

168603000

143191000

151267000

27591000

28527000

481000

12030000

21420000

8343000

7968000

356288000

368395000

398000

407000

627407000

623629000

-18419000

-9584000

-2028000

-3742000

607358000

610710000

963646000

979105000

1200000 2300000 1500000 3900000 4200000 7600000

0.01

5000000

0.01

250000000

39692999

40662856

39692999

40662856

94552000

92633000

188333000

180433000

11664000

13321000

24494000

25107000

106216000

105954000

212827000

205540000

51955000

49234000

103060000

96215000

11664000

13321000

24494000

25107000

14755000

14824000

29909000

28333000

2101000

1793000

4231000

3566000

9462000

12668000

18910000

25336000

89937000

91840000

180604000

178557000

16279000

14114000

32223000

26983000

-125000

-6000

-497000

-941000

-1808000

-5921000

-3602000

-11894000

-1933000

-5927000

-4099000

-12835000

14346000

8187000

28124000

14148000

4793000

3225000

10124000

5738000

9553000

4962000

18000000

8410000

0.24

0.15

0.44

0.26

0.23

0.15

0.44

0.26

40183000

32636000

40425000

32631000

40825000

32828000

41158000

32631000

2900000

4600000

6900000

12400000

400000 1700000 1100000 2900000 400000 1700000 1100000 2900000

1118000

-564000

1714000

8000

10671000

4398000

19714000

8418000

2234000

4275000

332000

1345000

-864000

-483000

744000

207000

-3405000

24825000

519000

8551000

-2855000

-2112000

-8398000

-1461000

-3510000 2372000

-294000

15017000

195000

2191000

29733000

20491000

6019000

5693000

515000

-29000

-40000

-6505000

-5653000

955000

102000

26405000

6187000

15036000

813000

744000

-32450000

-15678000

1145000

143000

-8077000

-697000

37407000

17737000

29330000

17040000

<div> (3) Net Income Per Share Basic and diluted earnings or loss per share (“EPS”) are computed using the two-class method, which is an earnings allocation that determines EPS for each class of common stock and participating securities according to dividends declared and participation rights in undistributed earnings. Restricted Stock Awards (“RSAs”) are considered participating securities because they are legally issued at the date of grant and holders are entitled to receive non-forfeitable dividends during the vesting term. The computation of diluted EPS includes additional common shares, such as unvested stock options with exercise prices less than the average market price of the Company’s common stock during the period (“in-the-money options”), which would be considered outstanding under the treasury stock method. The treasury stock method assumes that additional shares would have to be issued in cases where the exercise price of stock options is less than the value of the common stock being acquired because the cash proceeds received from the stock option holder would not be sufficient to acquire that same number of shares. The Company does not compute diluted EPS in cases where the inclusion of such additional shares would be anti-dilutive in effect. The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2017 and 2016, (in thousands, except for earnings per share):    <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,183</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,636</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,425</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,631</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RSAs</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total weighted-average shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,242</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,636</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,484</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,631</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Earnings per common share—Basic</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,553</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,962</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,000</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,410</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Undistributed earnings allocated to RSAs</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income available to common shareholders—Basic</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,539</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,962</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,974</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,410</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income per common share—Basic</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.24</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.15</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.26</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic weighted-average common shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,183</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,636</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,425</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,631</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of diluted shares</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">642</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">733</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted weighted-average shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,825</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,828</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,158</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,631</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income per common share—Diluted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.23</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.15</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.26</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>   During the three months ended June 30, 2017, there were 15,030 shares excluded from the computation of EPS because they were anti-dilutive under the treasury method calculation of diluted weighted average shares outstanding. During the six months ended June 30, 2017 and 2016, respectively, there were 46,124 and 25,584 shares excluded from the computation of EPS because they were anti-dilutive under the treasury method calculation of diluted weighted average shares outstanding. During the three months ended June 30, 2017, there were 697,850 stock options that were excluded from the computation of EPS due to the exercise price exceeding the average fair value of the Company’s common stock during the period. During the six months ended June 30, 2017 and 2016, respectively, there were 27,500 and 186,667 stock options that were excluded from the computation of EPS due to the exercise price exceeding the average fair value of the Company’s common stock during the period.  </div>

<div> Share Repurchases In April 2017, the Board of Directors (the “Board”) of the Company authorized a share repurchase program with an authorized repurchase level of $50.0 million. The share repurchase program, according to its terms, will expire in April 2018. Repurchases under the repurchase program may take place in the open market or negotiated transactions, at the discretion of the Company’s management. During the three and six months ended June 30, 2017, the Company repurchased 1,042,455 shares of its outstanding common stock for $26.4 million.</div>

<div> Recently Adopted Accounting Standards In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-01, Business Combinations. The standard changes the definition of a business to assist entities with evaluating when a set of transferred assets and activities is a business. Under the new guidance, an entity first determines whether substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or a group of similar identifiable assets. If this threshold is met, the set is not a business. If it’s not met, the entity then evaluates whether the set meets the requirement that a business include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create outputs.  ASU 2017-01 is effective for fiscal years beginning after December 15, 2017, and for interim periods within those fiscal years. The Company, as permitted, early adopted ASU 2017-01 using the prospective method in the second quarter of 2017. ASU 2017-01 was considered in the asset acquisition described in Note 2.   In November 2016, the FASB issued ASU 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash. The new guidance is intended to reduce diversity in practice by requiring the statement of cash flows to explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents. ASU 2016-18 is effective for fiscal years beginning after December 15, 2017, and for interim periods within those fiscal years. The Company, as permitted, early adopted ASU 2016-18 in the fourth quarter of 2016.  As a result of this adoption, cash flows resulting from changes in restricted cash balances, are no longer presented as a component of net cash provided by operating activities in the Company’s condensed consolidated statements of cash flows, but have been reclassified and combined within Increases/(Decreases) in Cash and Cash Equivalents and Restricted Cash.  This reclassification was retrospectively applied to all periods presented within the condensed consolidated statements of cash flows.   In March 2016, the FASB issued ASU No. 2016-09, Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting. The new guidance is intended to simplify certain aspects of accounting for share based payments to employees, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The Company elected to adopt this ASU in the first quarter of 2017 as required. The following summarizes the effects of the adoption on the Company's condensed consolidated financial statements:   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap">  </td> <td valign="top" style="width:3.33%;white-space:nowrap"> •</td> <td valign="top"> Income taxes - Upon adoption of this standard, all excess tax benefits and tax deficiencies (including tax benefits of dividends, if distributed, on share-based payment awards) are recognized as income tax expense or benefit in the statement of operations. The tax effects of exercised or vested awards are treated as discrete items in the reporting period in which they occur. As a result, the Company recognized discrete adjustments to income tax expense for the six months ended June 30, 2017 of less than $0.1 million related to excess tax benefits. The Company also recognizes excess tax benefits regardless of whether the benefit reduces taxes payable in the current period. The Company applied the prospective adoption approach for any unrecognized excess tax benefits beginning in 2017, which did not result in any cumulative-effect adjustment upon adoption. Prior periods have not been adjusted. </td></tr></table></div>   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap">  </td> <td valign="top" style="width:3.33%;white-space:nowrap"> •</td> <td valign="top"> Forfeitures - Prior to adoption, share-based compensation expense was recognized on a straight line basis, net of estimated forfeitures, such that expense was recognized only for share-based awards that were expected to vest. A forfeiture rate was estimated annually and revised, if necessary, in subsequent periods if actual forfeitures differed from initial estimates. Upon adoption, the Company no longer applies a forfeiture rate and instead accounts for forfeitures as they occur. The Company applied the modified retrospective adoption approach beginning in 2017 and booked an immaterial cumulative-effect adjustment to additional paid-in-capital and retained earnings within Shareholders’ Equity. Prior periods have not been adjusted.</td></tr></table></div>   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap">  </td> <td valign="top" style="width:3.33%;white-space:nowrap"> •</td> <td valign="top"> Statements of Cash Flows - The Company historically accounted for excess tax benefits on the Statement of Cash Flows as a financing activity. Upon adoption of this standard, excess tax benefits are classified along with other income tax cash flows as an operating activity. The Company elected to adopt this portion of the standard on a prospective basis beginning in 2017. Prior periods have not been adjusted. </td></tr></table></div>   <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap">  </td> <td valign="top" style="width:3.33%;white-space:nowrap"> •</td> <td valign="top"> Earnings Per Share - The Company uses the treasury stock method to compute diluted earnings per share, unless the effect would be anti-dilutive. Under this method, the Company is no longer required to estimate the tax rate and apply it to the dilutive share calculation for determining the dilutive earnings per share. The Company utilized the prospective adoption approach and applied this methodology beginning in 2017. Prior periods have not been adjusted.</td></tr></table></div> Upon adoption, no other aspects of ASU 2016-09 had an effect on the Company's condensed consolidated financial statements or related footnote disclosures. Recently Issued Accounting Standards In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842). The guidance in ASU 2016-02 supersedes the lease recognition requirements in ASC Topic 840, Leases (FAS 13). ASU 2016-02 requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases, along with additional qualitative and quantitative disclosures. ASU 2016-02 will be applied on a modified retrospective basis to each prior reporting period presented and is effective for fiscal years beginning after December 15, 2018, with early adoption permitted. The Company is currently evaluating the effect this standard will have on its condensed consolidated financial statements.   In May 2014, the FASB issued ASU No. 2014-09 ‘‘Revenue from Contracts with Customers,’’ to clarify the principles of recognizing revenue and create common revenue recognition guidance between US GAAP and International Financial Reporting Standards. In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net). In April 2016, the FASB issued ASU 2016-10, Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. In May 2016, the FASB issued ASU 2016-12, Narrow-Scope Improvements and Practical Expedients. In December 2016, the FASB issued ASU 2016-20 Technical Corrections and Improvements to Topic 606, Revenue From Contracts with Customers. ASUs’ 2016-20, 2016-12, 2016-10 and 2016-08 all clarify the interpretation guidance in ASU No. 2014-09, “Revenue from Contracts with Customers” specifically related to narrowing specific aspects of Topic 606 and adding illustrative examples to assist in the application of the guidance. The effective date and transition requirements in ASUs’ 2016-20, 2016-12, 2016-10, and 2016-08 are the same as the effective date and transition requirements of ASU 2014-09. ASU 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, deferred the original effective date of ASU 2014-09 by one year. The new standard allows for either a retrospective or modified retrospective approach to transition upon adoption. The new standard will be effective for annual reporting periods beginning after December 15, 2017. Early adoption is permitted for annual reporting periods beginning after December 15, 2016.   The Company continues to progress in its evaluation of potential impact of adopting this standard on its business policies, processes and systems, internal control over financial reporting environment,  and financial reporting and disclosures.  The Company expects that the majority of its contracts will have a single performance obligation and continues to assess the best measure of progress for recognition purposes.  The Company will adopt ASU 2014-09 as well as the clarified guidance in ASUs’ 2016-20, 2016-12, 2016-10, 2016-08, utilizing the modified retrospective approach, during the first quarter of 2018.  </div>

<div> The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2017 and 2016, (in thousands, except for earnings per share):    <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.14%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.86%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average shares:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,183</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,636</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,425</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,631</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RSAs</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total weighted-average shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,242</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,636</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,484</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,631</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Earnings per common share—Basic</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,553</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,962</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,000</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,410</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Undistributed earnings allocated to RSAs</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income available to common shareholders—Basic</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,539</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,962</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,974</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,410</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income per common share—Basic</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.24</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.15</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.26</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic weighted-average common shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,183</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,636</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,425</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,631</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of diluted shares</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">642</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">192</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">733</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted weighted-average shares outstanding</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,825</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,828</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,158</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,631</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net income per common share—Diluted</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.23</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.15</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.44</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.26</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> Intangible assets, net consisted of the following (in thousands):   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finite-lived intangible assets:</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying amount:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Backlog</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,630</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,630</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">145,051</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">145,051</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developed technologies</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,475</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,475</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,020</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,505</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total finite-lived intangible assets</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">275,176</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274,661</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated amortization:</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Backlog</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(72,630</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(72,630</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(79,464</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,267</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developed technologies</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(35,409</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(29,961</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,643</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,378</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:41.05pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accumulated amortization</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(189,146</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(170,236</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total finite-lived intangible assets, net</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,030</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104,425</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade name (indefinite-lived)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,646</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,646</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets, net</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">117,676</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">136,071</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> As of June 30, 2017, estimated amortization expense of the Company’s intangible assets for each of the next five years and thereafter is as follows (in thousands):   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Remainder of 2017</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,981</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,543</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,810</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,869</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,114</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Later years</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,713</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,030</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div>   Debt consisted of the following (in thousands):   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.22%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-size:8pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.5%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:73%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.5%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Term loan</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158,813</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">165,000</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less unamortized discount</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(466</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(534</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:73%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less unamortized term loan debt issuance costs</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(718</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.76%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.5%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(824</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:73%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less current portion of long-term debt</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,438</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(12,375</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:73%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term debt, net, less current portion</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">143,191</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.76%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.5%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,267</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> Principal payments on debt are due as follows (in thousands):   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:84.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2017 (remaining)</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,188</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:84.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2018</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,500</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:84.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2019</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,500</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:84.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.04%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,625</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:84.18%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99,000</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:84.18%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.04%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">158,813</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> The following table sets forth the Company’s Restricted Share activity:   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.92%;">  </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.38%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.92%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.92%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:24.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding and unvested - beginning of <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   period</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,258</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding and unvested - end of period</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,258</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cumulative vested shares - end of period</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,854,658</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.34%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

<div> Stock-based compensation expense recognized in the condensed consolidated statements of operations related to all outstanding stock based compensation awards is summarized below (in thousands):   <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="7" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.06%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30,</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-top:solid 0.75pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.12%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2016</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Direct costs, excluding depreciation and amortization</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">573</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,911</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,115</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.2%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,474</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">627</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,355</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,119</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,801</td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,200</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,266</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,234</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.2%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.12%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,275</td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>  </div>

50000000

2018-04

1042455

26400000

100000 1.00 1200000

500000

22200000 21100000 7600000 8500000 1400000 1200000 100000

21400000

40183000

32636000

40425000

32631000

59000

40242000 32636000 40484000 32631000

14000

26000

9539000

4962000

17974000

8410000

642000

192000

733000

15030000

46124000

25584000

697850000

27500000

186667000

0 0 0 0

50606000

48270000

28164000

34719000

2106000

3222000

72630000

145051000

54475000

3020000

2505000

275176000

274661000

72630000

79464000

66267000

35409000

29961000

1643000

1378000

189146000

170236000

86030000

104425000

31646000

18981000

29543000

14810000

7869000

5114000

9713000

13191000

21453000

3201000

2964000

158813000

165000000

466000

534000

718000

824000

6188000

16500000

20625000

99000000

27500

727550

P4Y

41346

P1Y

34812

P4Y

11111

2350166

768896

72579

125707

2920776

859212

17.57

28.35

15.24

20.80

20.32

15.34

59258

1854658

573000

1911000

1115000

2474000

627000

1355000

1119000

1801000

1200000

3266000

2234000

4275000

0.334

0.360

0.394

0.406

0.350

200000

100000

200000

100000

400000

1800000

4300000

5100000

11400000

400000 1600000 1000000 2900000 600000 2000000 3700000 6300000 1400000 3800000

100000

600000

400000

100000 300000 400000 1300000 100000 100000

200000

100000

300000

200000

100000 100000

500000

100000

600000

100000

300000 100000

200000

800000

400000

2017-01-11

P12Y

2022-11 1

P10Y

1100000

600000

2 2 2012 2027 1

P10Y

P15Y

1900000

1000000

1800000

1700000

27600000

28500000

17200000

18100000

300000

200000

600000

500000

700

22200000 100000 21400000 600000

100000

EX-101.SCH 7 medp-20170630.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) link:calculationLink link:presentationLink link:definitionLink 100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Acquisition link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Net Income Per Share link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Accounts Receivable And Unbilled, Net link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Intangible Assets, Net link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Accrued Expenses link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Debt link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Shareholder's Equity and Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Related Party Transactions link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Cash Flow Statement- Supplemental Information link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Basis of Presentation (Policies) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Net Income Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Accounts Receivable And Unbilled, Net (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Intangible Assets, Net (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Accrued Expenses (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Debt (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Shareholder's Equity and Stock-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Basis of Presentation - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Acquisition - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Net Income Per Share - Schedule of Reconciliation of Denominators and Additional Shares that are Excluded from the Calculation of EPS (Details) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Net Income Per Share - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Fair Value Measurements - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Accounts Receivable And Unbilled, Net - Schedule of Accounts Receivable and Unbilled, Net (Details) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets, Net (Details) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Intangible Assets, Net - Schedule of Estimated Amortization Expense of Intangible Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Debt - Schedule of Debt (Details) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Debt - Schedule of Principal Payments on Debt Due (Details) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Shareholder's Equity and Stock-Based Compensation - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Shareholder's Equity and Stock-Based Compensation - Schedule of Stock Option Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Shareholder's Equity and Stock-Based Compensation - Schedule of Restricted Share Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Shareholder's Equity and Stock-Based Compensation - Summary of Stock-Based Compensation Expense Recognized in Statements of Operations Related to All Outstanding Stock Based Compensation Awards (Details) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Income Taxes - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Related Party Transactions - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Cash Flow Statement- Supplemental Information - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 8 medp-20170630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 medp-20170630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 medp-20170630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Document and Entity Information [Abstract] Document And Entity Information [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Funds received in advance of study expenditures. Income Statement [Abstract] ASSETS Assets [Abstract] Current assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Restricted cash Restricted Cash And Cash Equivalents At Carrying Value Accounts receivable and unbilled, net (includes $1.2 million and $2.3 million with related parties at June 30, 2017 and December 31, 2016, respectively) Receivables Net Current Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Goodwill Goodwill Intangible assets, net Intangible Assets Net Excluding Goodwill Deferred income taxes Deferred Tax Assets Liabilities Net Noncurrent Other assets Other Assets Noncurrent Total assets Assets LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued expenses Accrued Liabilities Current Pre-funded study costs (includes $1.5 million and $3.9 million with related parties at June 30, 2017 and December 31, 2016, respectively) Pre Funded Study Costs Advanced billings (includes $4.2 million and $7.6 million with related parties at June 30, 2017 and December 31, 2016, respectively) Deferred Revenue Current Current portion of long-term debt Long Term Debt Current Other current liabilities Other Liabilities Current Total current liabilities Liabilities Current Long-term debt, net, less current portion Long Term Debt Noncurrent Deemed landlord liability, less current portion Capital Lease Obligations Noncurrent Deferred income tax liability Deferred Tax Liabilities Noncurrent Deferred credit Deferred Revenue And Credits Noncurrent Other long-term liabilities Other Liabilities Noncurrent Total liabilities Liabilities Commitments and contingencies (see Note 11) Commitments And Contingencies Shareholders’ equity: Stockholders Equity [Abstract] Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively Preferred Stock Value Common stock - $0.01 par-value; 250,000,000 shares authorized at June 30, 2017 and December 31, 2016, respectively; 39,692,999 and 40,662,856 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated deficit Retained Earnings Accumulated Deficit Accumulated other comprehensive loss Accumulated Other Comprehensive Income Loss Net Of Tax Total shareholders’ equity Stockholders Equity Total liabilities and shareholders’ equity Liabilities And Stockholders Equity Accounts receivable and unbilled, related parties, current. Funds received from related parties in advance of study expenditures. Advanced billings represents cash received from related parties or billed amounts per an agreed upon payment schedule where cash has not been received in advance of services being performed or revenue being recognized. Statement Of Financial Position [Abstract] Accounts receivable and unbilled, net with related parties Accounts Receivable And Unbilled Related Parties Current Pre-funded study costs with related parties Pre Funded Study Costs With Related Parties Advanced billings with related parties Deferred Revenue Current With Related Parties Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock shares authorized Preferred Stock Shares Authorized Preferred stock shares issued Preferred Stock Shares Issued Preferred stock shares outstanding Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock shares authorized Common Stock Shares Authorized Common stock shares issued Common Stock Shares Issued Common stock shares outstanding Common Stock Shares Outstanding Revenue: Revenues [Abstract] Service revenue, net (includes $2.9 million and $4.6 million with related parties for the three months ended June 30, 2017 and 2016, respectively, and $6.9 million and $12.4 million with related parties for the six months ended June 30, 2017 and 2016) Sales Revenue Services Net Reimbursed out-of-pocket revenue (includes $0.4 million and $1.7 million with related parties for the three months ended June 30, 2017 and 2016, respectively, and $1.1 million and $2.9 million with related parties for the six months ended June 30, 2017 and 2016) Reimbursement Revenue Total revenue Sales Revenue Net Operating expenses: Operating Expenses [Abstract] Direct costs, excluding depreciation and amortization Cost Of Services Excluding Depreciation Depletion And Amortization Reimbursed out-of-pocket expenses (includes $0.4 million and $1.7 million with related parties for the three months ended June 30, 2017 and 2016, respectively, and $1.1 million and $2.9 million with related parties for the six months ended June 30, 2017 and 2016) Cost Of Reimbursable Expense Selling, general and administrative Selling General And Administrative Expense Depreciation Depreciation Amortization Amortization Of Intangible Assets Total operating expenses Costs And Expenses Income from operations Operating Income Loss Other expense, net: Nonoperating Income Expense [Abstract] Miscellaneous expense, net Other Nonoperating Income Expense Interest expense, net Interest Income Expense Nonoperating Net Total other expense, net Nonoperating Income Expense Income before income taxes Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax provision Income Tax Expense Benefit Net income Net Income Loss Net income per share attributable to common shareholders: Earnings Per Share [Abstract] Basic Earnings Per Share Basic Diluted Earnings Per Share Diluted Weighted average common shares outstanding: Weighted Average Number Of Shares Outstanding [Abstract] Basic Weighted Average Number Of Shares Outstanding Basic Diluted Weighted Average Number Of Diluted Shares Outstanding Reimbursed out-of-pocket revenue with related parties including, but not limited to, travel, meetings, printing, and shipping and handling fees. Reimbursed out-of-pocket expenses with related parties including, but not limited to, travel, meetings, printing, and shipping and handling fees. Service revenue with related parties Revenue From Related Parties Reimbursed out-of-pocket revenue with related parties Reimbursed Out Of Pocket Revenue With Related Parties Reimbursed out-of-pocket expenses with related parties Reimbursed Out Of Pocket Expenses With Related Parties Statement Of Income And Comprehensive Income [Abstract] Net income Other comprehensive income (loss) Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Foreign currency translation adjustments, net of taxes Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Comprehensive income Comprehensive Income Net Of Tax Increase (decrease) in funds received in advance of study expenditures. Statement Of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided By Used In Operating Activities Continuing Operations [Abstract] Adjustments to reconcile net income to net cash (used in) provided by operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Stock-based compensation expense Share Based Compensation Amortization of debt issuance costs and discount Amortization Of Financing Costs And Discounts Deferred income tax benefit Deferred Income Tax Expense Benefit Other Other Noncash Income Expense Changes in assets and liabilities: Increase Decrease In Other Operating Assets And Liabilities Net [Abstract] Accounts receivable and unbilled, net Increase Decrease In Receivables Prepaid expenses and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Accounts payable Increase Decrease In Accounts Payable Accrued expenses Increase Decrease In Accrued Liabilities Pre-funded study costs Increase Decrease In Pre Funded Study Costs Advanced billings Increase Decrease In Deferred Revenue Other assets and liabilities, net Increase Decrease In Other Operating Capital Net Net cash provided by operating activities Net Cash Provided By Used In Operating Activities Continuing Operations CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided By Used In Investing Activities Continuing Operations [Abstract] Property and equipment expenditures Payments To Acquire Property Plant And Equipment Acquisition of intangibles Payments To Acquire Intangible Assets Other Payments For Proceeds From Other Investing Activities Net cash used in investing activities Net Cash Provided By Used In Investing Activities Continuing Operations CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided By Used In Financing Activities Continuing Operations [Abstract] Proceeds from stock option exercises Proceeds From Stock Options Exercised Repurchases of common stock Payments For Repurchase Of Common Stock Payment of debt Repayments Of Debt Payment of deemed landlord liability Repayments Of Long Term Capital Lease Obligations Net cash used in financing activities Net Cash Provided By Used In Financing Activities Continuing Operations EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — Beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — End of period Accounting Policies [Abstract] Basis of Presentation Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Asset acquisition. Asset acquisition. Asset Acquisition [Abstract] Acquisition Asset Acquisition [Text Block] Net Income Per Share Earnings Per Share [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Receivables [Abstract] Accounts Receivable And Unbilled, Net Loans Notes Trade And Other Receivables Disclosure [Text Block] Goodwill And Intangible Assets Disclosure [Abstract] Intangible Assets, Net Intangible Assets Disclosure [Text Block] Payables And Accruals [Abstract] Accrued Expenses Accounts Payable And Accrued Liabilities Disclosure [Text Block] Debt Disclosure [Abstract] Debt Debt Disclosure [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Shareholder's Equity and Stock-Based Compensation Shareholders Equity And Share Based Payments [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Related Party Transactions [Abstract] Related Party Transactions Related Party Transactions Disclosure [Text Block] Supplemental Cash Flow Information [Abstract] Cash Flow Statement- Supplemental Information Cash Flow Supplemental Disclosures [Text Block] Unaudited Interim Financial Information Basis Of Accounting Policy Policy [Text Block] Share repurchase program policy. Share Repurchases Share Repurchase Program Policy Policy [Text Block] Recently Adopted and Issued Accounting Standards New Accounting Pronouncements Policy Policy [Text Block] Schedule of Reconciliation of Denominators and Additional Shares that are Excluded from the Calculation of EPS Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Schedule of Accounts Receivable and Unbilled, Net Schedule Of Accounts Notes Loans And Financing Receivable [Text Block] Schedule of finite lived and indefinite lived intangible assets by major class. Schedule of Intangible Assets, Net Schedule Of Finite Lived And Indefinite Lived Intangible Assets By Major Class Table [Text Block] Schedule of Estimated Amortization Expense of Intangible Assets Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block] Schedule of Accrued Expenses Schedule Of Accrued Liabilities Table [Text Block] Schedule of Debt Schedule Of Debt Instruments [Text Block] Schedule of Principal Payments on Debt Due Schedule Of Maturities Of Long Term Debt Table [Text Block] Schedule of Stock Option Activity Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Schedule of Restricted Share Activity Schedule Of Sharebased Compensation Restricted Stock And Restricted Stock Units Activity Table [Text Block] Summary of Stock-Based Compensation Expense Recognized in Statements of Operations Related to All Outstanding Stock Based Compensation Awards Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Stock repurchase program expiration month and year. Basis of Presentation. Basis of presentation. Basis Of Presentation [Table] Basis Of Presentation [Table] Range Range [Axis] Range Range [Member] Maximum Maximum [Member] Adjustments for New Accounting Pronouncements Adjustments For New Accounting Pronouncements [Axis] Type of Adoption Type Of Adoption [Member] Accounting Standard Update (“ASU”) No. 2016-09 Accounting Standards Update201609 [Member] Basis Of Presentation [Line Items] Basis Of Presentation [Line Items] Stock repurchase program, authorized amount Stock Repurchase Program Authorized Amount1 Stock repurchase program, expiration date Stock Repurchase Program Expiration Month And Year Repurchases of outstanding common stock, shares Stock Repurchased And Retired During Period Shares Repurchases of outstanding common stock Discrete adjustments to income tax expense benefit. Discrete adjustments to income tax expense recognized Discrete Adjustments To Income Tax Expense Benefit Bankruptcy proceedings unsecured claim in exchange of common stock percentage. Business Combinations [Abstract] Noncash Or Part Noncash Acquisitions [Table] Noncash Or Part Noncash Acquisitions [Table] Noncash or Part Noncash Acquisitions by Unique Description Noncash Or Part Noncash Acquisitions By Unique Description [Axis] Noncash or Part Noncash Acquisition, Name Noncash Or Part Noncash Acquisition Name [Domain] NephroGenex Inc. NephroGenex, Inc. Nephro Genex Inc [Member] Noncash Or Part Noncash Acquisitions [Line Items] Noncash Or Part Noncash Acquisitions [Line Items] Bankruptcy proceedings unsecured claim in exchange of common stock percentage Bankruptcy Proceedings Unsecured Claim In Exchange Of Common Stock Percentage Noncash or part noncash acquisition, amount of consideration paid. Noncash or part noncash acquisition deferred tax assets. Noncash or part noncash acquisition, deferred tax assets acquired, net operating loss. Noncash or part noncash acquisition, deferred tax assets acquired, net operating loss, valuation allowance. Noncash or part noncash acquisition, deferred tax assets acquired, capitalized research and development expenses. Noncash or part noncash acquisition, deferred tax assets acquired, federal tax credits. Noncash or part noncash acquisition, deferred tax assets acquired, federal tax credits, valuation allowance Noncash or part noncash acquisition deferred tax liabilities. Consideration paid Noncash Or Part Noncash Acquisition Amount Of Consideration Paid Intangible assets Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 Deferred tax assets Noncash Or Part Noncash Acquisition Deferred Tax Assets Tax effected net operating losses Noncash Or Part Noncash Acquisition Deferred Tax Assets Acquired Net Operating Loss Tax effected net operating losses, valuation allowance Noncash Or Part Noncash Acquisition Deferred Tax Assets Acquired Net Operating Loss Valuation Allowance Tax effected capitalized research and development expenses Noncash Or Part Noncash Acquisition Deferred Tax Assets Acquired Capitalized Research And Development Expenses Tax effected federal tax credits Noncash Or Part Noncash Acquisition Deferred Tax Assets Acquired Federal Tax Credits Tax effected federal tax credits, valuation allowance Noncash Or Part Noncash Acquisition Deferred Tax Assets Acquired Federal Tax Credits Valuation Allowance Deferred tax liabilities Noncash Or Part Noncash Acquisition Deferred Tax Liabilities Weighted average number of common and restricted shares outstanding basic. EX-101.PRE 11 medp-20170630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2017	Jul. 28, 2017
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q2
Trading Symbol	MEDP
Entity Registrant Name	Medpace Holdings, Inc.
Entity Central Index Key	0001668397
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		39,486,848

XML 13 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 29,055	$ 37,099
Restricted cash	275	308
Accounts receivable and unbilled, net (includes $1.2 million and $2.3 million with related parties at June 30, 2017 and December 31, 2016, respectively)	76,664	79,767
Prepaid expenses and other current assets	17,129	16,074
Total current assets	123,123	133,248
Property and equipment, net	45,244	43,805
Goodwill	660,981	660,981
Intangible assets, net	117,676	136,071
Deferred income taxes	11,536	97
Other assets	5,086	4,903
Total assets	963,646	979,105
Current liabilities:
Accounts payable	7,195	10,911
Accrued expenses	16,392	24,417
Pre-funded study costs (includes $1.5 million and $3.9 million with related parties at June 30, 2017 and December 31, 2016, respectively)	48,530	51,948
Advanced billings (includes $4.2 million and $7.6 million with related parties at June 30, 2017 and December 31, 2016, respectively)	65,577	65,668
Current portion of long-term debt	14,438	12,375
Other current liabilities	3,130	3,284
Total current liabilities	155,262	168,603
Long-term debt, net, less current portion	143,191	151,267
Deemed landlord liability, less current portion	27,591	28,527
Deferred income tax liability	481	12,030
Deferred credit	21,420
Other long-term liabilities	8,343	7,968
Total liabilities	356,288	368,395
Commitments and contingencies (see Note 11)
Shareholders’ equity:
Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively
Common stock - $0.01 par-value; 250,000,000 shares authorized at June 30, 2017 and December 31, 2016, respectively; 39,692,999 and 40,662,856 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively	398	407
Additional paid-in capital	627,407	623,629
Accumulated deficit	(18,419)	(9,584)
Accumulated other comprehensive loss	(2,028)	(3,742)
Total shareholders’ equity	607,358	610,710
Total liabilities and shareholders’ equity	$ 963,646	$ 979,105

XML 14 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($) $ in Millions	Jun. 30, 2017	Dec. 31, 2016
Statement Of Financial Position [Abstract]
Accounts receivable and unbilled, net with related parties	$ 1.2	$ 2.3
Pre-funded study costs with related parties	1.5	3.9
Advanced billings with related parties	$ 4.2	$ 7.6
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock shares authorized	5,000,000	5,000,000
Preferred stock shares issued	0	0
Preferred stock shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock shares authorized	250,000,000	250,000,000
Common stock shares issued	39,692,999	40,662,856
Common stock shares outstanding	39,692,999	40,662,856

XML 15 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenue:
Service revenue, net (includes $2.9 million and $4.6 million with related parties for the three months ended June 30, 2017 and 2016, respectively, and $6.9 million and $12.4 million with related parties for the six months ended June 30, 2017 and 2016)	$ 94,552	$ 92,633	$ 188,333	$ 180,433
Reimbursed out-of-pocket revenue (includes $0.4 million and $1.7 million with related parties for the three months ended June 30, 2017 and 2016, respectively, and $1.1 million and $2.9 million with related parties for the six months ended June 30, 2017 and 2016)	11,664	13,321	24,494	25,107
Total revenue	106,216	105,954	212,827	205,540
Operating expenses:
Direct costs, excluding depreciation and amortization	51,955	49,234	103,060	96,215
Reimbursed out-of-pocket expenses (includes $0.4 million and $1.7 million with related parties for the three months ended June 30, 2017 and 2016, respectively, and $1.1 million and $2.9 million with related parties for the six months ended June 30, 2017 and 2016)	11,664	13,321	24,494	25,107
Selling, general and administrative	14,755	14,824	29,909	28,333
Depreciation	2,101	1,793	4,231	3,566
Amortization	9,462	12,668	18,910	25,336
Total operating expenses	89,937	91,840	180,604	178,557
Income from operations	16,279	14,114	32,223	26,983
Other expense, net:
Miscellaneous expense, net	(125)	(6)	(497)	(941)
Interest expense, net	(1,808)	(5,921)	(3,602)	(11,894)
Total other expense, net	(1,933)	(5,927)	(4,099)	(12,835)
Income before income taxes	14,346	8,187	28,124	14,148
Income tax provision	4,793	3,225	10,124	5,738
Net income	$ 9,553	$ 4,962	$ 18,000	$ 8,410
Net income per share attributable to common shareholders:
Basic	$ 0.24	$ 0.15	$ 0.44	$ 0.26
Diluted	$ 0.23	$ 0.15	$ 0.44	$ 0.26
Weighted average common shares outstanding:
Basic	40,183	32,636	40,425	32,631
Diluted	40,825	32,828	41,158	32,631

XML 16 R5.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Statement [Abstract]
Service revenue with related parties	$ 2.9	$ 4.6	$ 6.9	$ 12.4
Reimbursed out-of-pocket revenue with related parties	0.4	1.7	1.1	2.9
Reimbursed out-of-pocket expenses with related parties	$ 0.4	$ 1.7	$ 1.1	$ 2.9

XML 17 R6.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 9,553	$ 4,962	$ 18,000	$ 8,410
Other comprehensive income (loss)
Foreign currency translation adjustments, net of taxes	1,118	(564)	1,714	8
Comprehensive income	$ 10,671	$ 4,398	$ 19,714	$ 8,418

XML 18 R7.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 18,000	$ 8,410
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation	4,231	3,566
Amortization	18,910	25,336
Stock-based compensation expense	2,234	4,275
Amortization of debt issuance costs and discount	332	1,345
Deferred income tax benefit	(864)	(483)
Other	(744)	(207)
Changes in assets and liabilities:
Accounts receivable and unbilled, net	3,405	(24,825)
Prepaid expenses and other current assets	(519)	(8,551)
Accounts payable	(2,855)	(2,112)
Accrued expenses	(8,398)	(1,461)
Pre-funded study costs	(3,510)	2,372
Advanced billings	(294)	15,017
Other assets and liabilities, net	(195)	(2,191)
Net cash provided by operating activities	29,733	20,491
CASH FLOWS FROM INVESTING ACTIVITIES:
Property and equipment expenditures	(6,019)	(5,693)
Acquisition of intangibles	(515)	0
Other	29	40
Net cash used in investing activities	(6,505)	(5,653)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from stock option exercises	955	102
Repurchases of common stock	(26,405)	0
Payment of debt	(6,187)	(15,036)
Payment of deemed landlord liability	(813)	(744)
Net cash used in financing activities	(32,450)	(15,678)
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	1,145	143
DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	(8,077)	(697)
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — Beginning of period	37,407	17,737
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH — End of period	$ 29,330	$ 17,040

XML 19 R8.htm IDEA: XBRL DOCUMENT

Basis of Presentation

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Basis of Presentation

(1) Basis of Presentation

Description of Business

The Company’s operations are principally based in North America, Europe, and Asia.

Unaudited Interim Financial Information

Share Repurchases

Recently Adopted Accounting Standards

•

Upon adoption, no other aspects of ASU 2016-09 had an effect on the Company's condensed consolidated financial statements or related footnote disclosures.

Recently Issued Accounting Standards

XML 20 R9.htm IDEA: XBRL DOCUMENT

Acquisition	6 Months Ended
Acquisition	Jun. 30, 2017
Asset Acquisition [Abstract]
Acquisition	(2) Acquisition In May 2017, the Company acquired out of bankruptcy NephroGenex, Inc. (“Nephrogenex” or the “Debtor”), a publicly-held pharmaceutical company that had previously filed for relief under Chapter 11 of the United States Bankruptcy Code. The Company, which was the largest unsecured creditor of Nephrogenex, entered into an agreement through the bankruptcy process, to exchange its unsecured claim for 100% of the common stock in the post-bankruptcy, debt free Debtor. The assets of the acquired Debtor consist primarily of tax attributes as well as in-process research and development and other intangible assets. An analysis by the Company determined that substantially all the fair value of the assets on the date of acquisition is captured in the tax attributes, as the intangible assets account for a relatively immaterial portion of the fair market value of the total assets received. The acquisition of the Debtor was accounted for as an asset purchase. The Company allocated its consideration paid of $1.2 million, consisting of accounts receivable and unbilled receivables and transaction related costs, on a pro rata basis to the assets acquired based on their respective fair values. Acquired assets include intangible assets of $0.5 million, deferred tax assets of $22.2 million, consisting of tax effected net operating losses in the amount of $21.1 (partially offset with a $7.6 million valuation allowance), tax effected capitalized research and development expenses of $8.5 million and tax effected federal tax credits of $1.4 million (partially offset with a $1.2 million valuation allowance) and deferred tax liabilities of $0.1 million. The excess amount of fair value received over consideration paid of $21.4 million was recorded as a Deferred credit in the condensed consolidated balance sheets and will be recognized within Income tax provision in proportion to the realization of the deferred tax assets and federal tax credits prospectively.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Net Income Per Share

6 Months Ended

Jun. 30, 2017

Earnings Per Share [Abstract]

Net Income Per Share

(3) Net Income Per Share

The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2017 and 2016, (in thousands, except for earnings per share):


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Weighted-average shares:
Common shares outstanding		40,183		32,636		40,425		32,631
RSAs		59		-		59		-
Total weighted-average shares		40,242		32,636		40,484		32,631
Earnings per common share—Basic
Net income	$	9,553	$	4,962	$	18,000	$	8,410
Less: Undistributed earnings allocated to RSAs		14		-		26		-
Net income available to common shareholders—Basic	$	9,539	$	4,962	$	17,974	$	8,410

Net income per common share—Basic	$	0.24	$	0.15	$	0.44	$	0.26

Basic weighted-average common shares outstanding		40,183		32,636		40,425		32,631
Effect of diluted shares		642		192		733		-
Diluted weighted-average shares outstanding		40,825		32,828		41,158		32,631

Net income per common share—Diluted	$	0.23	$	0.15	$	0.44	$	0.26

XML 22 R11.htm IDEA: XBRL DOCUMENT

Fair Value Measurements	6 Months Ended
Fair Value Measurements	Jun. 30, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements	(4) Fair Value Measurements The Company follows accounting guidance related to fair value measurements that defines fair value, establishes a framework for measuring fair value, and establishes a hierarchy for inputs used in measuring fair value. This hierarchy maximizes the use of “observable” inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy specifies three levels based on the inputs, as follows: Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities. Level 2: Valuations based on directly observable inputs or unobservable inputs corroborated by market data. Level 3: Valuations based on unobservable inputs supported by little or no market activity representing management’s determination of assumptions of how market participants would price the assets or liabilities. The fair value of financial instruments such as cash and cash equivalents, accounts receivable and unbilled, net, accounts payable, accrued expenses and advanced billings approximate their carrying amounts due to their short term maturities. The Company does not have any recurring fair value measurements as of June 30, 2017. There were no transfers between Level 1, Level 2 or Level 3 during the three or six months ended June 30, 2017 and 2016.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 23 R12.htm IDEA: XBRL DOCUMENT

Accounts Receivable And Unbilled, Net

6 Months Ended

Jun. 30, 2017

Receivables [Abstract]

Accounts Receivable And Unbilled, Net

(5) Accounts Receivable And Unbilled, Net

Accounts receivable and unbilled, net includes service revenue and reimbursed out-of-pocket revenue. Accounts receivable and unbilled, net consisted of the following (in thousands):

	As of
	June 30,		December 31,
	2017		2016
Accounts receivable	$	50,606	$	48,270
Unbilled	28,164			34,719
Less allowance for doubtful accounts	(2,106)		(3,222)
Total accounts receivable and unbilled, net	$	76,664	$	79,767

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

XML 24 R13.htm IDEA: XBRL DOCUMENT

Intangible Assets, Net

6 Months Ended

Jun. 30, 2017

Goodwill And Intangible Assets Disclosure [Abstract]

Intangible Assets, Net

(6) Intangible Assets, Net

Intangible assets, net consisted of the following (in thousands):

	As of
	June 30,			December 31,
	2017			2016
Intangible assets:
Finite-lived intangible assets:
Carrying amount:
Backlog	$	72,630		$	72,630
Customer relationships		145,051			145,051
Developed technologies		54,475			54,475
Other		3,020			2,505
Total finite-lived intangible assets		275,176			274,661
Accumulated amortization:
Backlog		(72,630	)		(72,630	)
Customer relationships		(79,464	)		(66,267	)
Developed technologies		(35,409	)		(29,961	)
Other		(1,643	)		(1,378	)
Total accumulated amortization		(189,146	)		(170,236	)
Total finite-lived intangible assets, net		86,030			104,425
Trade name (indefinite-lived)		31,646			31,646
Total intangible assets, net	$	117,676		$	136,071

As of June 30, 2017, estimated amortization expense of the Company’s intangible assets for each of the next five years and thereafter is as follows (in thousands):

	Amortization
Remainder of 2017	$	18,981
2018		29,543
2019		14,810
2020		7,869
2021		5,114
Later years		9,713
	$	86,030

XML 25 R14.htm IDEA: XBRL DOCUMENT

Accrued Expenses

6 Months Ended

Jun. 30, 2017

Payables And Accruals [Abstract]

Accrued Expenses

(7) Accrued Expenses

Accrued expenses consisted of the following (in thousands):

	As of
	June 30,		December 31,
	2017		2016
Employee compensation and benefits	$	13,191	$	21,453
Other		3,201		2,964
Total accrued expenses	$	16,392	$	24,417

XML 26 R15.htm IDEA: XBRL DOCUMENT

Debt

6 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Debt

(8) Debt

Debt consisted of the following (in thousands):

	As of
	June 30,			December 31,
	2017			2016

Term loan	$	158,813		$	165,000
Less unamortized discount		(466	)		(534	)
Less unamortized term loan debt issuance costs		(718	)		(824	)
Less current portion of long-term debt		(14,438	)		(12,375	)
Long-term debt, net, less current portion	$	143,191		$	151,267

Principal payments on debt are due as follows (in thousands):

2017 (remaining)	$	6,188
2018		16,500
2019		16,500
2020		20,625
2021		99,000
Total	$	158,813

XML 27 R16.htm IDEA: XBRL DOCUMENT

Shareholder's Equity and Stock-Based Compensation

6 Months Ended

Jun. 30, 2017

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Shareholder's Equity and Stock-Based Compensation

(9) Shareholder’s Equity and Stock-Based Compensation

Award Activity

The following table sets forth the Company’s stock option activity:

	Six Months Ended June 30, 2017
				Weighted Average
	Stock Options			Exercise Price
Outstanding - beginning of period		2,350,166		$	17.57
Granted		768,896		$	28.35
Exercised		(72,579	)	$	15.24
Forfeited/Expired		(125,707	)	$	20.80
Outstanding - end of period		2,920,776		$	20.32

Exercisable - end of period		859,212		$	15.34

The following table sets forth the Company’s Restricted Share activity:

	Six Months Ended
	June 30, 2017
	Shares
Outstanding and unvested - beginning of period		59,258
Granted		-
Vested		-
Forfeited		-
Outstanding and unvested - end of period		59,258

Cumulative vested shares - end of period		1,854,658

Stock-based compensation expense recognized in the condensed consolidated statements of operations related to all outstanding stock based compensation awards is summarized below (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2017		2016		2017		2016
Direct costs, excluding depreciation and amortization	$	573	$	1,911	$	1,115	$	2,474
Selling, general and administrative		627		1,355		1,119		1,801
Total stock-based compensation expense	$	1,200	$	3,266	$	2,234	$	4,275

XML 28 R17.htm IDEA: XBRL DOCUMENT

Income Taxes	6 Months Ended
Income Taxes	Jun. 30, 2017
Income Tax Disclosure [Abstract]
Income Taxes	(10) Income Taxes The Company’s effective income tax rate was 33.4% and 36.0% for the three and six months ended June 30, 2017, respectively. The Company’s effective income tax rate was 39.4% and 40.6% for the three and six months ended June 30, 2016, respectively. The Company’s effective income tax rate for the three and six months ended June 30, 2017 varied from the U.S. statutory rate of 35.0% primarily due to the impact of state taxes, domestic and foreign uncertain tax positions and the tax impact associated with acquired tax attributes. The Company acquired deferred tax assets of $22.2 million, consisting of tax effected net operating losses in the amount of $21.1 (partially offset with a $7.6 million valuation allowance), tax effected capitalized research and development expenses of $8.5 million and tax effected federal tax credits of $1.4 million (partially offset with a $1.2 million valuation allowance) and deferred tax liabilities of $0.1 million. See Note 2 for further description of the asset acquisition that occurred in the second quarter of 2017.

XML 29 R18.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2017
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	(11) Commitments and Contingencies Legal Proceedings The Company is involved in legal proceedings from time to time in the ordinary course of its business, including employment claims and claims related to other business transactions. The Company cannot predict with certainty the outcome of such proceedings, but it believes that adequate reserves have been recorded and losses already recognized with respect to such actions were immaterial as of June 30, 2017 and December 31, 2016. There is a reasonable possibility that a loss exceeding amounts already recognized may be incurred related to these actions; however, the Company believes that such potential losses were immaterial as of June 30, 2017.

XML 30 R19.htm IDEA: XBRL DOCUMENT

Related Party Transactions	6 Months Ended
Related Party Transactions	Jun. 30, 2017
Related Party Transactions [Abstract]
Related Party Transactions	(12) Related Party Transactions Employee Loans The Company periodically extends short term loans or advances to employees, typically upon commencement of employment. Total receivables as a result of these employee advances of $0.2 million existed at June 30, 2017 and December 31, 2016, respectively, and are included in the Prepaid expenses and other current assets and Other assets line items of the condensed consolidated balance sheets, respectively, depending on the contractual repayment date. Management Fees In conjunction with the IPO, the Advisory Services Agreement with Cinven Capital Management (V) General Partner Limited (“Cinven”) expired. Subsequent to the IPO, the Company pays fees for director services provided by Cinven employees that are members of the Company’s Board of Directors and any related committees. The director fees are paid directly to Cinven in accordance with the Company’s non-employee director compensation policy. During the three and six months ended June 30, 2016, the Company incurred management fees to Cinven of $0.1 million and $0.2 million, respectively, in the Company’s condensed consolidated statements of operations. Service Agreements Symplmed Pharmaceuticals, LLC (“Symplmed”) Medpace Investors LLC, a noncontrolling shareholder of the Company that is owned by employees of the Company and managed by the Company’s chief executive officer, has a majority ownership interest in Symplmed, a private pharmaceutical development company. In addition, the chief executive officer and other executives of the Company are board members of Symplmed. The Company has operated under a Master Services Agreement (“MSA”) with Symplmed since 2013 (amended in 2014) to perform clinical trial related services. Certain task orders governed by this arrangement were amended in the third quarter of 2016, changing the fee structure from unitized in nature to time and materials and revised pricing to more appropriately reflect market pricing based on the Company’s leveraging of this work to develop and enhance certain new service capabilities. The Company has evaluated its relationship with Symplmed and concluded that Symplmed is not a variable interest entity because the Company has no direct ownership interest or relationship other than the MSA. During the three months ended June 30, 2017 and 2016, the Company recognized service revenue from Symplmed of less than $0.1 million and $0.1 million, respectively, and during the six months ended June 30, 2017 and 2016, the Company recognized service revenue from Symplmed of less than $0.1 million and $0.4 million, respectively, in the Company’s condensed consolidated statements of operations. Coherus BioSciences, Inc. (“Coherus”) The chief executive officer of the Company is a member of Coherus’s board of directors. During the three months ended June 30, 2017 and 2016, the Company recognized service revenue from Coherus of $1.8 million and $4.3 million, respectively, and during the six months ended June 30, 2017 and 2016, the Company recognized service revenue from Coherus of $5.1 million and $11.4 million, respectively, in the Company’s condensed consolidated statements of operations. In addition, the company recognized Reimbursed out-of-pocket revenue and Reimbursed out-of-pocket expenses with Coherus in the condensed consolidated statements of operations of $0.4 million and $1.6 million during the three months ended June 30, 2017 and 2016, respectively, and $1.0 million and $2.9 million during the six months ended June 30, 2017 and 2016. As of June 30, 2017 and December 31, 2016, respectively, the Company had Accounts receivable and unbilled, net from Coherus of $0.6 million and $2.0 million recorded in the condensed consolidated balance sheets. As of June 30, 2017 and December 31, 2016, respectively, the Company had, from Coherus, $3.7 million and $6.3 million of Advanced billings and $1.4 million and $3.8 million of Pre-funded study costs, in the condensed consolidated balance sheets. Xenon Pharmaceuticals, Inc. (“Xenon”) Certain executives and employees of the Company, including the chief executive officer, have held equity investments in Xenon, a clinical-stage biopharmaceutical company. During the second quarter of 2017, the chief executive officer sold his entire equity position held in Xenon. During July 2015 the Company and Xenon entered into an amended MSA agreement for the Company to provide clinical trial related services. The Company recognized service revenue from Xenon of $0.1 million and $0.1 million during the three months ended June 30, 2017 and 2016, respectively, and service revenue from Xenon of $0.6 million and $0.4 million during the six months ended June 30, 2017 and 2016, respectively, in the Company’s condensed consolidated statements of operations. As of June 30, 2017 and December 31, 2016, respectively, the Company had Accounts receivable and unbilled, net from Xenon of less than $0.1 million and $0.3 million recorded in the condensed consolidated balance sheets. As of June 30, 2017 and December 31, 2016, respectively, the Company had, from Xenon, $0.4 million and $1.3 million of Advanced billings and $0.1 million and $0.1 million of Pre-funded study costs, in the condensed consolidated balance sheets. Cymabay Therapeutics, Inc. (“Cymabay”) Cymabay is a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, including serious rare and orphan disorders. During the first quarter of 2016, it was announced that a Medpace employee would join Cymabay’s board of directors. The Company and Cymabay entered into a MSA dated October 21, 2016. Subsequently, the Company and Cymabay have entered into several task orders for the Company to perform clinical trial related services. During the three months ended June 30, 2017 and 2016, the Company recognized service revenue from Cymabay of $0.2 million and $0.1 million, respectively, and during the six months ended June 30, 2017 and 2016, the Company recognized service revenue from Cymabay of $0.3 million and $0.2 million, respectively, in the Company’s condensed consolidated statements of operations. As of June 30, 2017 and December 31, 2016, respectively, the Company had Accounts receivable and unbilled, net from Cymabay of $0.1 million and less than $0.1 million recorded in the condensed consolidated balance sheets. LIB Therapeutics LLC (“LIB”) Certain executives and employees of the Company, including the chief executive officer, are members of LIB’s board of managers. The Company entered into a MSA dated November 24, 2015 with LIB, a company that engages in research, development, marketing and commercialization of pharmaceutical drugs. Subsequently, the Company and LIB have entered into several task orders for the Company to perform clinical trial related services. During the three months ended June 30, 2017 and 2016, the Company recognized service revenue from LIB of $0.5 million and less than $0.1 million, respectively, and during the six months ended June 30, 2017 and 2016, the Company recognized service revenue from LIB of $0.6 million and less than $0.1 million, respectively, in the Company’s condensed consolidated statements of operations. As of June 30, 2017 and December 31, 2016, respectively, the Company had Accounts receivable and unbilled, net from LIB of $0.3 million and less than $0.1 million recorded in the condensed consolidated balance sheets. CinRX Pharma, LLC (“CinRX”) Certain executives and employees of the Company, including the chief executive officer, are members of CinRX’s board of managers and/or have equity investments in CinRX, a biotech company. The Company and CinRX have entered into several task orders for the Company to perform clinical trial related services. During the three and six months ended June 30, 2017, the Company recognized service revenue from CinRX of $0.2 million, respectively, in the Company’s condensed consolidated statements of operations. Medpace Investors, LLC Medpace Investors is a noncontrolling shareholder and related party of Medpace Holdings, Inc. Medpace Investors is owned and managed by employees of the Company. The chief executive officer of Medpace is also the manager and majority unit holder of Medpace Investors. The Company acted as a paying agent for Medpace Investors with taxing authorities principally in instances when employee tax payments or remittance of withholdings related to equity compensation are required. During the three and six months ended June 30, 2016, the Company paid $0.2 million and $0.8 million to various taxing authorities on behalf of Medpace Investors. Purchase of Real Estate Properties In December 2016, the Company entered into a purchase agreement for four parcels of real estate property that are closely situated to the Medpace campus in Cincinnati, Ohio, from AT Redevelopment Company, LLC, which is wholly-owned by the Company’s chief executive officer. The purchase price of the real estate property was $0.4 million as determined by an independent third party broker's opinion of value. The transaction closed on January 11, 2017. Leased Real Estate Headquarters Lease The Company entered into an operating lease for its corporate headquarters with an entity that is wholly owned by the chief executive officer of the Company. The Company has evaluated its relationship with the related party and concluded that the related party is not a variable interest entity because the Company has no direct ownership interest or relationship other than the lease. The lease for headquarters is for an initial term of twelve years through November 2022 with a renewal option for one 10-year term at prevailing market rates. The Company pays rent, taxes, insurance, and maintenance expenses that arise from the use of the property. Annual base rent for the corporate headquarters allows for adjustments to the rental rate annually for increases in the consumer price index. Lease expense recognized for each of the three months ended June 30, 2017 and 2016 was $0.6 million, respectively, and lease expense recognized for each of the six months ended June 30, 2017 and 2016 was $1.1 million, respectively. The lease expense was allocated between Direct costs, excluding depreciation and amortization, and Selling, general and administrative in the condensed consolidated statements of operations. Deemed Assets and Deemed Landlord Liabilities The Company entered into two multi-year lease agreements governing the occupancy of space of two buildings in Cincinnati, Ohio with an entity that is wholly owned by the Company’s chief executive officer and certain members of his immediate family. In accordance with the accounting guidance related to leases, the Company was deemed in substance to be the owner of the property during the construction phase and at completion. Accordingly, the Company reflected the buildings and related liabilities as deemed assets from landlord building construction in Property and equipment, net, Other current liabilities, and Deemed landlord liability, less current portion, respectively, on the condensed consolidated balance sheets. The Company assumed occupancy in 2012 and the leases expire in 2027 with the Company having one 10-year option to extend the lease term. The deemed assets are being fully depreciated, on a straight line basis, over the 15-year term of the lease. Deemed landlord liabilities are recorded at their net present value when the Company enters into qualifying leases and are reduced as the Company makes periodic lease payments on the properties. Accretion expense is being recorded over the term of the lease as a component of Interest expense, net in the Company’s condensed consolidated statements of operations. The Company paid $1.0 million during the three months ended June 30, 2017 and 2016, respectively, and $1.9 million during the six months ended June 30, 2017 and 2016. The current and long-term portions of the Deemed landlord liability at June 30, 2017 were $1.8 million and $27.6 million, respectively. The current and long-term portions of the Deemed landlord liability at December 31, 2016 were $1.7 million and $28.5 million, respectively. The Company has recognized deemed assets, net of $17.2 million and $18.1 million at June 30, 2017 and December 31, 2016, respectively, in the condensed consolidated balance sheets. Travel Services The Company incurs expenses for travel services for company executives provided by a private aviation charter company that is owned by the chief executive officer and the executive vice president of operations of the Company (“private aviation charter”). The Company may contract directly with the private aviation charter for the use of its aircraft or indirectly through a third party aircraft management and jet charter company (the “Aircraft Management Company”). The travel services provided are primarily for business purposes, with certain personal travel paid for as part of the executives’ compensation arrangements. The Aircraft Management Company also makes the private aviation charter aircraft available to third parties. The Company incurred travel expenses of $0.3 million and $0.2 million during the three months ended June 30, 2017 and 2016, respectively, and $0.6 million and $0.5 during the six months ended June 30, 2017 and 2016, respectively, related to these travel services. These travel expenses are recorded in Selling, general and administrative in the Company’s condensed consolidated statements of operations.

XML 31 R20.htm IDEA: XBRL DOCUMENT

Cash Flow Statement- Supplemental Information

6 Months Ended

Jun. 30, 2017

Supplemental Cash Flow Information [Abstract]

Cash Flow Statement- Supplemental Information

(13) Cash Flow Statement- Supplemental Information

During the six months ended June 30, 2017, the Company engaged in the following significant non-cash investing and financing activities:

•

XML 32 R21.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Policies)

6 Months Ended

Jun. 30, 2017

Accounting Policies [Abstract]

Unaudited Interim Financial Information

Share Repurchases

Recently Adopted and Issued Accounting Standards

Recently Adopted Accounting Standards

•

Upon adoption, no other aspects of ASU 2016-09 had an effect on the Company's condensed consolidated financial statements or related footnote disclosures.

Recently Issued Accounting Standards

XML 33 R22.htm IDEA: XBRL DOCUMENT

Net Income Per Share (Tables)

6 Months Ended

Jun. 30, 2017

Earnings Per Share [Abstract]

Schedule of Reconciliation of Denominators and Additional Shares that are Excluded from the Calculation of EPS

The following table sets forth the computation of basic and diluted earnings per share for the three and six months ended June 30, 2017 and 2016, (in thousands, except for earnings per share):


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2017		2016		2017		2016
Weighted-average shares:
Common shares outstanding		40,183		32,636		40,425		32,631
RSAs		59		-		59		-
Total weighted-average shares		40,242		32,636		40,484		32,631
Earnings per common share—Basic
Net income	$	9,553	$	4,962	$	18,000	$	8,410
Less: Undistributed earnings allocated to RSAs		14		-		26		-
Net income available to common shareholders—Basic	$	9,539	$	4,962	$	17,974	$	8,410

Net income per common share—Basic	$	0.24	$	0.15	$	0.44	$	0.26

Basic weighted-average common shares outstanding		40,183		32,636		40,425		32,631
Effect of diluted shares		642		192		733		-
Diluted weighted-average shares outstanding		40,825		32,828		41,158		32,631

Net income per common share—Diluted	$	0.23	$	0.15	$	0.44	$	0.26

XML 34 R23.htm IDEA: XBRL DOCUMENT

Accounts Receivable And Unbilled, Net (Tables)

6 Months Ended

Jun. 30, 2017

Receivables [Abstract]

Schedule of Accounts Receivable and Unbilled, Net

Accounts receivable and unbilled, net consisted of the following (in thousands):

	As of
	June 30,		December 31,
	2017		2016
Accounts receivable	$	50,606	$	48,270
Unbilled	28,164			34,719
Less allowance for doubtful accounts	(2,106)		(3,222)
Total accounts receivable and unbilled, net	$	76,664	$	79,767

XML 35 R24.htm IDEA: XBRL DOCUMENT

Intangible Assets, Net (Tables)

6 Months Ended

Jun. 30, 2017

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets, Net

Intangible assets, net consisted of the following (in thousands):

	As of
	June 30,			December 31,
	2017			2016
Intangible assets:
Finite-lived intangible assets:
Carrying amount:
Backlog	$	72,630		$	72,630
Customer relationships		145,051			145,051
Developed technologies		54,475			54,475
Other		3,020			2,505
Total finite-lived intangible assets		275,176			274,661
Accumulated amortization:
Backlog		(72,630	)		(72,630	)
Customer relationships		(79,464	)		(66,267	)
Developed technologies		(35,409	)		(29,961	)
Other		(1,643	)		(1,378	)
Total accumulated amortization		(189,146	)		(170,236	)
Total finite-lived intangible assets, net		86,030			104,425
Trade name (indefinite-lived)		31,646			31,646
Total intangible assets, net	$	117,676		$	136,071

Schedule of Estimated Amortization Expense of Intangible Assets

As of June 30, 2017, estimated amortization expense of the Company’s intangible assets for each of the next five years and thereafter is as follows (in thousands):

	Amortization
Remainder of 2017	$	18,981
2018		29,543
2019		14,810
2020		7,869
2021		5,114
Later years		9,713
	$	86,030

XML 36 R25.htm IDEA: XBRL DOCUMENT

Accrued Expenses (Tables)

6 Months Ended

Jun. 30, 2017

Payables And Accruals [Abstract]

Schedule of Accrued Expenses

Accrued expenses consisted of the following (in thousands):

	As of
	June 30,		December 31,
	2017		2016
Employee compensation and benefits	$	13,191	$	21,453
Other		3,201		2,964
Total accrued expenses	$	16,392	$	24,417

XML 37 R26.htm IDEA: XBRL DOCUMENT

Debt (Tables)

6 Months Ended

Jun. 30, 2017

Debt Disclosure [Abstract]

Schedule of Debt

Debt consisted of the following (in thousands):

	As of
	June 30,			December 31,
	2017			2016

Term loan	$	158,813		$	165,000
Less unamortized discount		(466	)		(534	)
Less unamortized term loan debt issuance costs		(718	)		(824	)
Less current portion of long-term debt		(14,438	)		(12,375	)
Long-term debt, net, less current portion	$	143,191		$	151,267

Schedule of Principal Payments on Debt Due

Principal payments on debt are due as follows (in thousands):

2017 (remaining)	$	6,188
2018		16,500
2019		16,500
2020		20,625
2021		99,000
Total	$	158,813

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21521-112644

+ Details

XML 38 R27.htm IDEA: XBRL DOCUMENT

Shareholder's Equity and Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2017

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Schedule of Stock Option Activity

The following table sets forth the Company’s stock option activity:

	Six Months Ended June 30, 2017
				Weighted Average
	Stock Options			Exercise Price
Outstanding - beginning of period		2,350,166		$	17.57
Granted		768,896		$	28.35
Exercised		(72,579	)	$	15.24
Forfeited/Expired		(125,707	)	$	20.80
Outstanding - end of period		2,920,776		$	20.32

Exercisable - end of period		859,212		$	15.34

Schedule of Restricted Share Activity

The following table sets forth the Company’s Restricted Share activity:

	Six Months Ended
	June 30, 2017
	Shares
Outstanding and unvested - beginning of period		59,258
Granted		-
Vested		-
Forfeited		-
Outstanding and unvested - end of period		59,258

Cumulative vested shares - end of period		1,854,658

Summary of Stock-Based Compensation Expense Recognized in Statements of Operations Related to All Outstanding Stock Based Compensation Awards

Stock-based compensation expense recognized in the condensed consolidated statements of operations related to all outstanding stock based compensation awards is summarized below (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2017		2016		2017		2016
Direct costs, excluding depreciation and amortization	$	573	$	1,911	$	1,115	$	2,474
Selling, general and administrative		627		1,355		1,119		1,801
Total stock-based compensation expense	$	1,200	$	3,266	$	2,234	$	4,275

XML 39 R28.htm IDEA: XBRL DOCUMENT

Basis of Presentation - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended	6 Months Ended
	Apr. 30, 2017	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016
Basis Of Presentation [Line Items]
Stock repurchase program, expiration date	2018-04
Repurchases of outstanding common stock, shares		1,042,455	1,042,455
Repurchases of outstanding common stock		$ 26,400,000	$ 26,405,000	$ 0
Maximum
Basis Of Presentation [Line Items]
Stock repurchase program, authorized amount	$ 50,000,000
Maximum \| Accounting Standard Update (“ASU”) No. 2016-09
Basis Of Presentation [Line Items]
Discrete adjustments to income tax expense recognized			$ 100,000

XML 40 R29.htm IDEA: XBRL DOCUMENT

Acquisition - Additional Information (Details) - USD ($) $ in Thousands	1 Months Ended	6 Months Ended
	May 31, 2017	Jun. 30, 2017
Noncash Or Part Noncash Acquisitions [Line Items]
Deferred tax assets		$ 22,200
Deferred tax liabilities		100
Deferred credit		$ 21,420
NephroGenex, Inc.
Noncash Or Part Noncash Acquisitions [Line Items]
Bankruptcy proceedings unsecured claim in exchange of common stock percentage	100.00%
Consideration paid	$ 1,200
Intangible assets	500
Deferred tax assets	22,200
Tax effected net operating losses	21,100
Tax effected net operating losses, valuation allowance	7,600
Tax effected capitalized research and development expenses	8,500
Tax effected federal tax credits	1,400
Tax effected federal tax credits, valuation allowance	1,200
Deferred tax liabilities	100
Deferred credit	$ 21,400

XML 41 R30.htm IDEA: XBRL DOCUMENT

Net Income Per Share - Schedule of Reconciliation of Denominators and Additional Shares that are Excluded from the Calculation of EPS (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Weighted-average shares:
Basic weighted-average common shares outstanding	40,183	32,636	40,425	32,631
Total weighted-average shares	40,242	32,636	40,484	32,631
Earnings per common share—Basic
Net income	$ 9,553	$ 4,962	$ 18,000	$ 8,410
Net income available to common shareholders—Basic	$ 9,539	$ 4,962	$ 17,974	$ 8,410
Net income per common share—Basic	$ 0.24	$ 0.15	$ 0.44	$ 0.26
Basic weighted-average common shares outstanding	40,183	32,636	40,425	32,631
Effect of diluted shares	642	192	733	0
Diluted weighted-average shares outstanding	40,825	32,828	41,158	32,631
Net income per common share—Diluted	$ 0.23	$ 0.15	$ 0.44	$ 0.26
RSAs
Weighted-average shares:
Basic weighted-average common shares outstanding	59	0	59	0
Earnings per common share—Basic
Less: Undistributed earnings allocated to RSAs	$ 14	$ 0	$ 26	$ 0
Basic weighted-average common shares outstanding	59	0	59	0
Common Stock
Weighted-average shares:
Basic weighted-average common shares outstanding	40,183	32,636	40,425	32,631
Earnings per common share—Basic
Basic weighted-average common shares outstanding	40,183	32,636	40,425	32,631

XML 42 R31.htm IDEA: XBRL DOCUMENT

Net Income Per Share - Additional Information (Details) - shares shares in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted EPS	15,030	46,124	25,584
Stock Options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted EPS	697,850	27,500	186,667

XML 43 R32.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Fair Value Disclosures [Abstract]
Fair value measurements transfers between level 1, level 2, or level 3	$ 0	$ 0	$ 0	$ 0

XML 44 R33.htm IDEA: XBRL DOCUMENT

Accounts Receivable And Unbilled, Net - Schedule of Accounts Receivable and Unbilled, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Accounts Notes And Loans Receivable Net Current [Abstract]
Accounts receivable	$ 50,606	$ 48,270
Unbilled	28,164	34,719
Less allowance for doubtful accounts	(2,106)	(3,222)
Total accounts receivable and unbilled, net	$ 76,664	$ 79,767

XML 45 R34.htm IDEA: XBRL DOCUMENT

Intangible Assets, Net - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Finite-lived intangible assets:
Total finite-lived intangible assets	$ 275,176	$ 274,661
Accumulated amortization:
Total accumulated amortization	(189,146)	(170,236)
Total finite-lived intangible assets, net	86,030	104,425
Trade name (indefinite-lived)	31,646	31,646
Total intangible assets, net	117,676	136,071
Backlog
Finite-lived intangible assets:
Total finite-lived intangible assets	72,630	72,630
Accumulated amortization:
Total accumulated amortization	(72,630)	(72,630)
Customer Relationships
Finite-lived intangible assets:
Total finite-lived intangible assets	145,051	145,051
Accumulated amortization:
Total accumulated amortization	(79,464)	(66,267)
Developed Technologies
Finite-lived intangible assets:
Total finite-lived intangible assets	54,475	54,475
Accumulated amortization:
Total accumulated amortization	(35,409)	(29,961)
Other
Finite-lived intangible assets:
Total finite-lived intangible assets	3,020	2,505
Accumulated amortization:
Total accumulated amortization	$ (1,643)	$ (1,378)

XML 46 R35.htm IDEA: XBRL DOCUMENT

Intangible Assets, Net - Schedule of Estimated Amortization Expense of Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Goodwill And Intangible Assets Disclosure [Abstract]
Remainder of 2017	$ 18,981
2018	29,543
2019	14,810
2020	7,869
2021	5,114
Later years	9,713
Total finite-lived intangible assets, net	$ 86,030	$ 104,425

XML 47 R36.htm IDEA: XBRL DOCUMENT

Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Accrued Liabilities And Other Liabilities [Abstract]
Employee compensation and benefits	$ 13,191	$ 21,453
Other	3,201	2,964
Total accrued expenses	$ 16,392	$ 24,417

XML 48 R37.htm IDEA: XBRL DOCUMENT

Debt - Schedule of Debt (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
Term loan	$ 158,813	$ 165,000
Less unamortized discount	(466)	(534)
Less unamortized term loan debt issuance costs	(718)	(824)
Less current portion of long-term debt	(14,438)	(12,375)
Long-term debt, net, less current portion	$ 143,191	$ 151,267

XML 49 R38.htm IDEA: XBRL DOCUMENT

Debt - Schedule of Principal Payments on Debt Due (Details) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
2017 (remaining)	$ 6,188
2018	16,500
2019	16,500
2020	20,625
2021	99,000
Term loan	$ 158,813	$ 165,000

XML 50 R39.htm IDEA: XBRL DOCUMENT

Shareholder's Equity and Stock-Based Compensation - Additional Information (Details) - shares	3 Months Ended	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2017	Jun. 30, 2016
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options granted		768,896
Restricted Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares granted		0
2016 Incentive Award Plan \| Vesting After Four Years
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options granted	27,500	727,550
Award vesting period	4 years	4 years
2016 Incentive Award Plan \| Vesting After One Year \| Non-employee Directors
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options granted	41,346	41,346
Award vesting period	1 year	1 year
2014 Equity Incentive Plan \| Restricted Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares granted			11,111
2014 Equity Incentive Plan \| Vesting Equally Over Four Years
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock options granted			34,812
Award vesting period			4 years

XML 51 R40.htm IDEA: XBRL DOCUMENT

Shareholder's Equity and Stock-Based Compensation - Schedule of Stock Option Activity (Details) - $ / shares	6 Months Ended
	Jun. 30, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Number of Stock Options, Outstanding - beginning of period	2,350,166
Number of Stock Options, Granted	768,896
Number of Stock Options, Exercised	(72,579)
Number of Stock Options, Forfeited/Expired	(125,707)
Number of Stock Options, Outstanding - end of period	2,920,776
Number of Stock Options, Exercisable - end of period	859,212
Weighted average exercise price, Outstanding - beginning of period	$ 17.57
Weighted average exercise price, Granted	28.35
Weighted average exercise price, Exercised	15.24
Weighted average exercise price, Forfeited/Expired	20.80
Weighted average exercise price, Outstanding - end of period	20.32
Weighted average exercise price, Exercisable - end of period	$ 15.34

XML 52 R41.htm IDEA: XBRL DOCUMENT

Shareholder's Equity and Stock-Based Compensation - Schedule of Restricted Share Activity (Details) - Restricted Awards	6 Months Ended
	Jun. 30, 2017 shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Outstanding and unvested - beginning of period	59,258
Granted	0
Vested	0
Forfeited	0
Outstanding and unvested - end of period	59,258
Cumulative vested shares - end of period	1,854,658

XML 53 R42.htm IDEA: XBRL DOCUMENT

Shareholder's Equity and Stock-Based Compensation - Summary of Stock-Based Compensation Expense Recognized in Statements of Operations Related to All Outstanding Stock Based Compensation Awards (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 1,200	$ 3,266	$ 2,234	$ 4,275
Direct Costs, Excluding Depreciation and Amortization
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	573	1,911	1,115	2,474
Selling, General and Administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total stock-based compensation expense	$ 627	$ 1,355	$ 1,119	$ 1,801

XML 54 R43.htm IDEA: XBRL DOCUMENT

Income Taxes - Additional Information (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		6 Months Ended
	May 31, 2017	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Income Tax Disclosure [Line Items]
Effective income tax rate		33.40%	39.40%	36.00%	40.60%
U.S. statutory rate		35.00%		35.00%
Deferred tax assets				$ 22.2
Deferred tax liabilities				$ 0.1
NephroGenex, Inc.
Income Tax Disclosure [Line Items]
Deferred tax assets	$ 22.2
Tax effected net operating losses	21.1
Tax effected net operating losses, valuation allowance	7.6
Tax effected capitalized research and development expenses	8.5
Tax effected federal tax credits	1.4
Tax effected federal tax credits, valuation allowance	1.2
Deferred tax liabilities	$ 0.1

XML 55 R44.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Additional Information (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($) RenewalOption Agreement Building	Jun. 30, 2016 USD ($)	Dec. 31, 2016 USD ($) Parcel
Related Party Transaction [Line Items]
Service revenue with related parties	$ 2,900,000	$ 4,600,000	$ 6,900,000	$ 12,400,000
Reimbursed out-of-pocket revenue with related parties	400,000	1,700,000	1,100,000	2,900,000
Accounts receivable and unbilled, net	1,200,000		1,200,000		$ 2,300,000
Advanced billings	4,200,000		4,200,000		7,600,000
Pre-funded study costs with related parties	1,500,000		1,500,000		3,900,000
Deemed landlord liability, long-term portions	27,591,000		27,591,000		28,527,000
Cinven
Related Party Transaction [Line Items]
Management fees expense with related party		100,000		200,000
Medpace Investors
Related Party Transaction [Line Items]
Related party tax expense		200,000		800,000
Employee Loans
Related Party Transaction [Line Items]
Employee advances receivables	200,000		200,000
Employee Loans \| Other Assets
Related Party Transaction [Line Items]
Employee advances receivables					200,000
Service Agreements \| Symplmed
Related Party Transaction [Line Items]
Service revenue with related parties				400,000
Service Agreements \| Symplmed \| Maximum
Related Party Transaction [Line Items]
Service revenue with related parties	100,000	100,000	100,000
Service Agreements \| Coherus Bio Sciences Inc
Related Party Transaction [Line Items]
Service revenue with related parties	1,800,000	4,300,000	5,100,000	11,400,000
Reimbursed out-of-pocket revenue with related parties	400,000	1,600,000	1,000,000	2,900,000
Accounts receivable and unbilled, net	600,000		600,000		2,000,000
Advanced billings	3,700,000		3,700,000		6,300,000
Pre-funded study costs with related parties	1,400,000		1,400,000		3,800,000
Service Agreements \| Xenon
Related Party Transaction [Line Items]
Service revenue with related parties	100,000	100,000	600,000	400,000
Accounts receivable and unbilled, net					300,000
Advanced billings	400,000		400,000		1,300,000
Pre-funded study costs with related parties	100,000		100,000		100,000
Service Agreements \| Xenon \| Maximum
Related Party Transaction [Line Items]
Accounts receivable and unbilled, net	100,000		100,000
Service Agreements \| Cymabay
Related Party Transaction [Line Items]
Service revenue with related parties	200,000	100,000	300,000	200,000
Accounts receivable and unbilled, net	100,000		100,000
Service Agreements \| Cymabay \| Maximum
Related Party Transaction [Line Items]
Accounts receivable and unbilled, net					100,000
Service Agreements \| LIB
Related Party Transaction [Line Items]
Service revenue with related parties	500,000		600,000
Accounts receivable and unbilled, net	300,000		300,000
Service Agreements \| LIB \| Maximum
Related Party Transaction [Line Items]
Service revenue with related parties		100,000		100,000
Accounts receivable and unbilled, net					$ 100,000
Service Agreements \| CinRX
Related Party Transaction [Line Items]
Service revenue with related parties	200,000		200,000
Purchase of Real Estate Properties \| Chief Executive Officer
Related Party Transaction [Line Items]
Number of parcel in real estate property \| Parcel					4
Purchase price of real estate property			$ 400,000
Transaction closed date			Jan. 11, 2017
Leased Real Estate \| Chief Executive Officer
Related Party Transaction [Line Items]
Term of lease			12 years
Lease expiration period			2022-11
Number of lease renewal, 10-year option \| RenewalOption			1
Lease term upon renewal			10 years
Lease expense recognized	600,000	600,000	$ 1,100,000	1,100,000
Leased Real Estate \| Chief Executive Officer And Immediate Family
Related Party Transaction [Line Items]
Term of lease			15 years
Number of lease renewal, 10-year option \| RenewalOption			1
Lease term upon renewal			10 years
Number of lease agreements \| Agreement			2
Number of buildings \| Building			2
Lease occupancy year			2012
Lease expiration year			2027
Accretion expense paid	1,000,000	1,000,000	$ 1,900,000	1,900,000
Deemed landlord liability, current	1,800,000		1,800,000		$ 1,700,000
Deemed landlord liability, long-term portions	27,600,000		27,600,000		28,500,000
Leased Real Estate \| Property and Equipment, Net \| Chief Executive Officer And Immediate Family \| Building
Related Party Transaction [Line Items]
Deemed assets, net	17,200,000		17,200,000		$ 18,100,000
Travel Services \| Chief Executive Officer
Related Party Transaction [Line Items]
Travel expenses with related party	$ 300,000	$ 200,000	$ 600,000	$ 500,000

XML 56 R45.htm IDEA: XBRL DOCUMENT

Cash Flow Statement- Supplemental Information - Additional Information (Details)	6 Months Ended
	Jun. 30, 2017 USD ($)
Supplemental Cash Flow Information [Abstract]
Acquisition of net assets	$ 700
Deferred tax assets, net	22,200,000
Deferred tax liabilities, net	100,000
Deferred credits	21,400,000
Accounts receivable and unbilled, net	600,000
Other assets	$ 100,000

EXCEL 57 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 58 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 59 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 61 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 104 214 1 false 36 0 false 8 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.medpace.com/20170630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Sheet http://www.medpace.com/20170630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) Statements 2 false false R3.htm 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Sheet http://www.medpace.com/20170630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITEDParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Sheet http://www.medpace.com/20170630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) Statements 4 false false R5.htm 100040 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parenthetical) Sheet http://www.medpace.com/20170630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSUNAUDITEDParenthetical CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (Parenthetical) Statements 5 false false R6.htm 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Sheet http://www.medpace.com/20170630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) Statements 6 false false R7.htm 100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Sheet http://www.medpace.com/20170630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Statements 7 false false R8.htm 100070 - Disclosure - Basis of Presentation Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureBasisOfPresentation Basis of Presentation Notes 8 false false R9.htm 100080 - Disclosure - Acquisition Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureAcquisition Acquisition Notes 9 false false R10.htm 100090 - Disclosure - Net Income Per Share Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureNetIncomePerShare Net Income Per Share Notes 10 false false R11.htm 100100 - Disclosure - Fair Value Measurements Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 100110 - Disclosure - Accounts Receivable And Unbilled, Net Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureAccountsReceivableAndUnbilledNet Accounts Receivable And Unbilled, Net Notes 12 false false R13.htm 100120 - Disclosure - Intangible Assets, Net Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureIntangibleAssetsNet Intangible Assets, Net Notes 13 false false R14.htm 100130 - Disclosure - Accrued Expenses Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureAccruedExpenses Accrued Expenses Notes 14 false false R15.htm 100140 - Disclosure - Debt Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureDebt Debt Notes 15 false false R16.htm 100150 - Disclosure - Shareholder's Equity and Stock-Based Compensation Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureShareholderSEquityAndStockBasedCompensation Shareholder's Equity and Stock-Based Compensation Notes 16 false false R17.htm 100160 - Disclosure - Income Taxes Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 17 false false R18.htm 100170 - Disclosure - Commitments and Contingencies Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 100180 - Disclosure - Related Party Transactions Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 19 false false R20.htm 100190 - Disclosure - Cash Flow Statement- Supplemental Information Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureCashFlowStatementSupplementalInformation Cash Flow Statement- Supplemental Information Notes 20 false false R21.htm 100200 - Disclosure - Basis of Presentation (Policies) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureBasisOfPresentationPolicies Basis of Presentation (Policies) Policies 21 false false R22.htm 100210 - Disclosure - Net Income Per Share (Tables) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureNetIncomePerShareTables Net Income Per Share (Tables) Tables http://www.medpace.com/20170630/taxonomy/role/DisclosureNetIncomePerShare 22 false false R23.htm 100220 - Disclosure - Accounts Receivable And Unbilled, Net (Tables) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureAccountsReceivableAndUnbilledNetTables Accounts Receivable And Unbilled, Net (Tables) Tables http://www.medpace.com/20170630/taxonomy/role/DisclosureAccountsReceivableAndUnbilledNet 23 false false R24.htm 100230 - Disclosure - Intangible Assets, Net (Tables) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureIntangibleAssetsNetTables Intangible Assets, Net (Tables) Tables http://www.medpace.com/20170630/taxonomy/role/DisclosureIntangibleAssetsNet 24 false false R25.htm 100240 - Disclosure - Accrued Expenses (Tables) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://www.medpace.com/20170630/taxonomy/role/DisclosureAccruedExpenses 25 false false R26.htm 100250 - Disclosure - Debt (Tables) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureDebtTables Debt (Tables) Tables http://www.medpace.com/20170630/taxonomy/role/DisclosureDebt 26 false false R27.htm 100260 - Disclosure - Shareholder's Equity and Stock-Based Compensation (Tables) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureShareholderSEquityAndStockBasedCompensationTables Shareholder's Equity and Stock-Based Compensation (Tables) Tables http://www.medpace.com/20170630/taxonomy/role/DisclosureShareholderSEquityAndStockBasedCompensation 27 false false R28.htm 100270 - Disclosure - Basis of Presentation - Additional Information (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformationDetails Basis of Presentation - Additional Information (Details) Details 28 false false R29.htm 100280 - Disclosure - Acquisition - Additional Information (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureAcquisitionAdditionalInformationDetails Acquisition - Additional Information (Details) Details 29 false false R30.htm 100290 - Disclosure - Net Income Per Share - Schedule of Reconciliation of Denominators and Additional Shares that are Excluded from the Calculation of EPS (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureNetIncomePerShareScheduleOfReconciliationOfDenominatorsAndAdditionalSharesThatAreExcludedFromCalculationOfEPSDetails Net Income Per Share - Schedule of Reconciliation of Denominators and Additional Shares that are Excluded from the Calculation of EPS (Details) Details 30 false false R31.htm 100300 - Disclosure - Net Income Per Share - Additional Information (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureNetIncomePerShareAdditionalInformationDetails Net Income Per Share - Additional Information (Details) Details 31 false false R32.htm 100310 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 32 false false R33.htm 100320 - Disclosure - Accounts Receivable And Unbilled, Net - Schedule of Accounts Receivable and Unbilled, Net (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureAccountsReceivableAndUnbilledNetScheduleOfAccountsReceivableAndUnbilledNetDetails Accounts Receivable And Unbilled, Net - Schedule of Accounts Receivable and Unbilled, Net (Details) Details 33 false false R34.htm 100330 - Disclosure - Intangible Assets, Net - Schedule of Intangible Assets, Net (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfIntangibleAssetsNetDetails Intangible Assets, Net - Schedule of Intangible Assets, Net (Details) Details 34 false false R35.htm 100340 - Disclosure - Intangible Assets, Net - Schedule of Estimated Amortization Expense of Intangible Assets (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureIntangibleAssetsNetScheduleOfEstimatedAmortizationExpenseOfIntangibleAssetsDetails Intangible Assets, Net - Schedule of Estimated Amortization Expense of Intangible Assets (Details) Details 35 false false R36.htm 100350 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails Accrued Expenses - Schedule of Accrued Expenses (Details) Details 36 false false R37.htm 100360 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureDebtScheduleOfDebtDetails Debt - Schedule of Debt (Details) Details 37 false false R38.htm 100370 - Disclosure - Debt - Schedule of Principal Payments on Debt Due (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureDebtScheduleOfPrincipalPaymentsOnDebtDueDetails Debt - Schedule of Principal Payments on Debt Due (Details) Details 38 false false R39.htm 100380 - Disclosure - Shareholder's Equity and Stock-Based Compensation - Additional Information (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureShareholderSEquityAndStockBasedCompensationAdditionalInformationDetails Shareholder's Equity and Stock-Based Compensation - Additional Information (Details) Details 39 false false R40.htm 100390 - Disclosure - Shareholder's Equity and Stock-Based Compensation - Schedule of Stock Option Activity (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureShareholderSEquityAndStockBasedCompensationScheduleOfStockOptionActivityDetails Shareholder's Equity and Stock-Based Compensation - Schedule of Stock Option Activity (Details) Details 40 false false R41.htm 100400 - Disclosure - Shareholder's Equity and Stock-Based Compensation - Schedule of Restricted Share Activity (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureShareholderSEquityAndStockBasedCompensationScheduleOfRestrictedShareActivityDetails Shareholder's Equity and Stock-Based Compensation - Schedule of Restricted Share Activity (Details) Details 41 false false R42.htm 100410 - Disclosure - Shareholder's Equity and Stock-Based Compensation - Summary of Stock-Based Compensation Expense Recognized in Statements of Operations Related to All Outstanding Stock Based Compensation Awards (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureShareholderSEquityAndStockBasedCompensationSummaryOfStockBasedCompensationExpenseRecognizedInStatementsOfOperationsRelatedToAllOutstandingStockBasedCompensationAwardsDetails Shareholder's Equity and Stock-Based Compensation - Summary of Stock-Based Compensation Expense Recognized in Statements of Operations Related to All Outstanding Stock Based Compensation Awards (Details) Details 42 false false R43.htm 100420 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 43 false false R44.htm 100430 - Disclosure - Related Party Transactions - Additional Information (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetails Related Party Transactions - Additional Information (Details) Details 44 false false R45.htm 100440 - Disclosure - Cash Flow Statement- Supplemental Information - Additional Information (Details) Sheet http://www.medpace.com/20170630/taxonomy/role/DisclosureCashFlowStatementSupplementalInformationAdditionalInformationDetails Cash Flow Statement- Supplemental Information - Additional Information (Details) Details 45 false false All Reports Book All Reports medp-20170630.xml medp-20170630.xsd medp-20170630_cal.xml medp-20170630_def.xml medp-20170630_lab.xml medp-20170630_pre.xml true true ZIP 63 0001564590-17-014638-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-17-014638-xbrl.zip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end